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2020 by the International Consortium for Health Outcomes Measurement (ICHOM).   
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ENGLISH SUMMARY 
This PhD thesis includes three studies and four papers which were done as part of the 
development and initial evaluation of the Danish diabetes Patient Reported Outcome 
(PRO) questionnaire and a digital PRO dialogue tool, DiaProfil, for routine diabetes 
care in Denmark. The thesis focuses on the systematic use of patient involvement. 
The overall aim of the research was to develop a PRO diabetes tool, improve active 
participation of people with diabetes (PWD) regarding their care, improve the quality 
of the dialogue between PWD and health care professionals (HCP), and help 
individualize care based on what generates most value for the individual.  
The first study (study I) used systematic patient involvement methods to define a 
core set of diabetes outcome constructs for use in Denmark for value-based diabetes 
care which explicitly reflects the priorities of PWD. The study found that according 
to PWD both clinician and patient reported outcomes are required to adequately 
evaluate outcomes of diabetes care in Denmark. Multi-stakeholder consensus was 
reached for a first Danish national set of patient-important diabetes outcomes which 
require the assessment of psychological well-being, diabetes related distress and 
quality of life, symptom distress, medicine experience, confidence in self-
management and access to person-centered diabetes care and support1 beyond existing 
clinical outcomes (primarily A1c, late stage complications and hospitalization). 
The second study (study II) aimed to evaluate feasibility, acceptability, benefits and 
risks, and implementation barriers and facilitators of the PRO diabetes tool among 
PWD and HCP in routine outpatient diabetes care. The study was a clinical single-
arm mixed-method pilot study designed as part of the iterative formative evaluation 
of the Danish PRO tool with PWD as partners to guide refinement and larger scale 
evaluation of the PRO diabetes tool. The study found that the PRO diabetes 
questionnaire and the digital dialogue tool were both feasible, acceptable and 
appropriate for use by PWD and HCP in routine visits. The study also provided initial 
confirmation that the PRO tool can improve the active participation of the PWD in 
own care and the quality of the dialogue by increasing focus during the visit on what 
matters most to the PWD2. 
The third study (study III) involved the design of a study protocol and Likert-scale 
evaluation questionnaires for assessment of psychometric and clinical validity, reach, 
perceived effectiveness, and barriers and facilitators to implementation in different 
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health care settings in Denmark. A single-arm mixed-method multi-center 
implementation study protocol (M-PRODIA) and psychometrically tested evaluation 
questionnaires were developed using the RE-AIM (Reach, Efficacy, Adoption, 
Implementation and Maintenance) framework and methods for patient involvement. 
The study protocol was implemented nationally in 2020 with collection of qualitative 
and quantitative PRO and PRO evaluation data from more than 550 PWD and 30 HCP 
in hospital, municipality and primary care settings over the course of one year3. 
In addition to the three main studies, this thesis includes a narrative review paper (the 
fourth paper), which synthesizes recent studies and methodological developments 
within the specific field of research pertaining to use of PRO in routine diabetes care.  
This paper presents recommendations, tools and best practice cases pertaining to the 
design of digital PRO tools for use in diabetes care with systematic involvement of 
PWD and HCP in the process4. 
This thesis led to identification of patient-important PRO constructs for use in value-
based diabetes care in Denmark, confirmed that the Danish PRO diabetes tool is 
acceptable and feasible for use in routine visits according to both PWD and HCP and 
identified how the tool may benefit PWD and improve the quality of diabetes care.  
The studies applied systematic approaches to involvement of PWD and demonstrated 
the importance of soliciting the experiences and views of PWD during the design and 
the evaluation of PRO tools intended for routine care.  
The final Danish PRO diabetes questionnaire was approved and recommended for 
national use by the steering group for PRO under the Danish Ministry of Health and 
the Danish Health Data Authority in March 2021. Implementation of the tool is now 
underway in several health care settings. 
 
It is my hope that the methods for involvement of PWD in the design of the Danish 
PRO diabetes tool presented in this thesis and the initial study results regarding 
hypothesized benefits of using the PRO diabetes tool in practice can inspire future 
research in patient involvement and effectiveness of PRO tools for use in clinical 
practice. 
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DANSK RESUME 
Denne Phd afhandling indeholder 3 studier og 4 artikler, der er udført som del af  den 
videnskabelige udvikling og initiale evaluering af det danske PRO diabetes 
spørgeskema og et digitalt PRO dialogværktøj, DiaProfil til brug i den rutinemæssige 
diabetesbehandling. Afhandlingen fokuserer på anvendelsen af systematiske tilgange 
til brugerinvolvering i udviklingen. Det overordnede formål med arbejdet var at 
udvikle et PRO diabetes værktøj, der kan styrke den aktive deltagelse af personer med 
diabetes i egen behandling, forbedre kvaliteten af dialogen mellem borger og 
behandler og målrette behandlingen ud fra hvad der skaber mest værdi for den enkelte.  
Det første studie anvendte metoder til systematisk patientinvolvering til at definere 
det første danske sæt af effektmål til brug i værdibaseret diabetesbehandling som 
reflekterer personer med diabetes’ perspektiv og prioriteter. Studiet viste, at ifølge 
personer med diabetes bør evaluering af diabetesbehandlingen indbefatte både 
kliniske og patient-rapporterede effektmål. Studiet første til national ekspert 
konsensus om et set patient-vigtige effektmål for diabetes som udover etablerede 
kliniske kvalitetsindikatorer såsom blodsukkerregulering, senfølger og hospitalisering 
indbefatter psykologisk velbefindende, diabetes relateret stress og effekt på 
livskvalitet, symptombelastning, medicin oplevelse, tiltro til egenomsorgsevne og 
tryghed ved adgang til personcentreret behandling og støtte. 
Det andet studie evaluerede feasibility og acceptabilitet, gavn og risici samt 
hæmmere og fremmere for implementering af PRO diabetes værktøjet i den 
rutinemæssige diabetesbehandling. Studie var designet som et enkelt-arms mixed-
method pilot studie i samarbejde med personer med diabetes og indgik i den iterative 
formative evaluering af PRO diabetes værktøjet med henblik på at underbygge 
designet af et større evalueringsstudie. Studiet viste, at PRO diabetes spørgeskemaet 
samt den digitale PRO løsning, DiaProfil var anvendelige og acceptable til brug i 
praksis for både personer med diabetes og sundhedsprofessionelle i rutinemæssige 
diabeteskonsultationer. Studiet underbyggede derudover hypoteserne, at PRO 
diabetesværkøjet kan føre til at personen med diabetes er mere aktivt deltagende i 
egen behandling og forbedre kvaliteten af dialogen mellem borger og behandler ved 
at fremme fokus på hvad der er vigtigst for den enkelte person. 
Det tredje studie indbefattede designet af en studie protokol og Likert-skala 
spørgeskemaer til evaluering af udbredelse, oplevet effekt og gavn og fremmere og 
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hæmmere af implementering samt psykometrisk og klinisk validitet af PRO diabetes 
redskabet i flere sundhedssektorer i Danmark. En protokol for et enkelt-arms mixed-
method implementerings studie (M-PRODIA) blev designet og psykometrisk 
afprøvede skemaer blev udviklet med udgangspunkt i RE-AIM (Reach, Efficacy, 
Adoption, Implementation and Maintenance) metoderammen og ved brug af 
systematisk patientinvolvering. Studieprotokollen blev implementeret nationalt i 2020 
hvor kvalitative og kvantitative data PRO og PRO evalueringsdata blev indsamlet fra 
flere end 550 personer med diabetes og 30 sundhedsprofessionelle fra både hospital, 
kommune og almen praksis over en pilot periode på 1 år.  
 
Udover de 3 studier, indbefatter afhandlingen en narrativ oversigtsartikel, der 
sammenfatter de nyeste studier og metodemæssige udviklinger indenfor det 
specifikke forskningsfelt for brug af PRO i den rutinemæssige diabetesbehandling. 
Artiklen indbefatter anbefalinger, værktøjer og illustrative best practice cases for 
udviklingen af PRO værktøjer til klinisk brug ved hjælp af systematisk involvering af 
personer med diabetes. 
Studierne i afhandlingen har identificeret patient-vigtige effektmål til brug i 
værdibaseret diabetes behandling i Danmark, bekræftet at det danske PRO diabetes 
værktøj opleves som anvendeligt og acceptabelt i rutinemæssige diabetessamtaler og 
har potentialet til at gavne personen med diabetes og behandlingskvaliteten.  
Studierne anvendte systematiske metoder til patient involvering og viser vigtigheden 
af at anvende erfaringer og perspektiver fra personer med diabetes i udviklingen af 
PRO redskaber til klinisk brug. Det danske PRO diabetes spørgeskema blev godkendt 
og anbefalet til nationalt brug af Sundhedsministeriets styregruppe for PRO samt af 
sundhedsdatastyrelsen i marts 2021 og implementering er allerede i gang flere steder. 
 
Det er mit håb at de anvendte metoder til involvering af personer med diabetes i 
designet af PRO diabetes værktøjet samt de initiale resultater angående PRO-
værktøjets forventede gavn i klinisk praksis kan inspirere fremtidig forskning i patient 
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PREFACE  
My past experiences of working to understand and amplify the perspective of people 
with diabetes in diabetes research and health care in order to improve access to person-
centered diabetes care and treatments has shaped my approach to the research studies 
in this thesis. 
Through my work as co-principal investigator and study lead of the Diabetes Attitudes 
Wishes and Needs (DAWN) studies 5–7, I have gained substantial experience 
involving a wide range of diabetes stakeholders in society including People With 
Diabetes (PWD) in a participatory design of a global research protocol to advance 
person-centered diabetes research and care8. The study involved diabetes population 
surveys in 17 countries with PRO questionnaires, and the results were used to guide 
national strategies to increase delivery of person-centered and psychosocial diabetes 
care 5. 
Through my work as co-developer of multiple diabetes-specific PRO questionnaires 
for research and care, I have obtained hands-on experience regarding the use of 
interviews, focus groups, literature analysis, and surveys as well as psychometric and 
statistical methods for psychometric development and validation of diabetes PROs. 
Working as a PRO researcher from within the clinical diabetes care team at the 
Department of Endocrinology at Aalborg University Hospital for the past 3.5 years 
has provided a unique environment for mutual learning and innovation in relation to 
finding ways to put the perspective of both PWD and clinicians center stage in the 
detailed process of development and evaluation of a digital PRO tool for clinical use. 
A foundation for my research continues to aim at involving PWD and other relevant 
stakeholders as equal partners in all research phases. 
I started as the PRO lead in the clinical care team at Aalborg University Hospital 
(Aalborg, Denmark) in 2017 and had the responsibility for conceptualizing, planning, 
designing, and carrying out patient involvement research studies to support each phase 
of the conceptualization, development and evaluation of the Danish PRO diabetes 
questionnaire and a new digital PRO dialogue tool (DiaProfil). These tools were to 
be used on a large scale to advance value-based person-centered diabetes care in 
Denmark. 
At the end of 2017, I undertook the first study involving PWD to identify the basis for 
using PRO and clinical indicators for evaluating outcomes for diabetes in Denmark. 
In 2018, I developed the scientific methods and participatory strategies that supported 
the national iterative participatory development process for the Danish PRO diabetes 
questionnaire.  
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In 2019, I oversaw the scientific finalization of the new digital PRO diabetes tool, 
DiaProfil for use by health professionals and conducted the first clinical pilot study 
of the PRO diabetes questionnaire. I then conceptualized and designed study III — 
the multi-center pilot study protocol, M-PRODIA — using the implementation 
framework of RE-AIM as a guide as we developed a series of psychometric evaluation 
questionnaires for use by PWD, HCP, and diabetes centers. 
In 2020, I oversaw the scientific collection of quantitative and qualitative data for the 
multi-center pilot study at 7 diabetes centers across 3 Danish regions.  
In January 2021, I conducted preliminary scientific analyses using the study data for 
use in the national evaluation report of the Health Data Authority. The report 
concluded that the PRO diabetes tool was acceptable, feasible and perceived as value-
adding for use in routine diabetes by the participating diabetes clinics and centers. 
This thesis includes three selected studies and four papers which were conceived and 
done by the author of this thesis from June 2017- February 2021 at AAUH (Aalborg 
University Hospital, Denmark) and AAU (Aalborg University, Denmark) in 
continuous collaboration with the clinical diabetes care team at AAUH.  
 
Most of the research undertaken for the development and evaluation of the PRO 
diabetes tool is still ongoing. This thesis therefore presents only a subset of the overall 
work and focuses specifically on the systematic approaches to patient involvement. 
The main research questions that are addressed are:  
• Which diabetes outcomes are important to measure in routine diabetes care from 
the perspectives of PWD and their family members and other stakeholders?  
• Is the Danish PRO diabetes tool feasible and acceptable for use in routine diabetes 
care visits? Does the PRO diabetes tool improve active participation of PWD in 
their care and improve the quality of dialogue between PWD and HCP? What are 
the possible mechanisms of actions?  
• How can experiences of PWD and HCP related to the validity, acceptability, 
efficacy and implementation of the PRO diabetes tool be assessed as part of real-
world testing in routine diabetes care?  
Study I presents the first nationally endorsed set of outcome constructs for use in 
diabetes care which reflects the priorities and perspectives of PWD in Denmark.  
Study II presents the first initial evaluation of acceptability and hypothesized impacts 
of the use of PRO diabetes tool when used in standard outpatient diabetes care visits.  
Study III describes a mixed-method study protocol including purpose-built 
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psychometric evaluation questionnaires and data collection tools guided by the RE-
AIM framework to enable evaluation of implementation and public health impact 
potential of the PRO diabetes tool across multiple health care settings. 
Paper IV presents a narrative review of the emerging new research field pertaining to 
the integrated use of digital PRO tools in coordinated diabetes care 4.  
The funding for the work presented in this thesis was provided by Region North 
Denmark and the Danish Health Data Authority. 
The thesis includes the following original papers: 
1. Skovlund, S.E., Troelsen, L, Klim, L., Jakobsen, P.E., Ejskjaer, N.  
The development of a national core set of person-centered diabetes outcome 
constructs for use in routine diabetes care across healthcare sectors. 
Submitted to BMC Patient Research Involvement and Engagement Journal. 
February 25, 2021. 
 
2. Skovlund, S.E., Troelsen, L, Noergaard, L.M., Pietraszek, A., Jakobsen, 
P.E., Ejskjaer, N. 
Feasibility and Acceptability of a Digital Patient Reported Outcomes (PRO) 
Tool in Routine Outpatient Diabetes Care: A Mixed-Method Formative Pilot 
Study. Submitted to JMIR Formative Research Journal, March 1, 2021. 
 
3. Skovlund, S.E., Nicolucci, A., Balk-Møller, N.C., Berthelsen, D.B., Glümer, 
C, Perrild, H, Nørgaard, L.M., Troelsen, L., Kjær, P., Pietraszek, A., Hessler, 
D. Kaplan, S., Ejskjaer, N. 
Perceived Benefits, Barriers and Facilitators of a Digital Patient Reported 
Outcomes (PRO) Tool in Routine Diabetes Care: A National Multi-Center 
Mixed-Method Pilot Study (M-PRODIA). Submitted to JMIR Journal of 
Research Protocols, March 4, 2021. 
 
4. Skovlund, S. E., Lichtenberg, TH., Hessler, D. Jakobsen, P.E., Ejskjaer, N., 
Can the Routine Use of Patient-Reported Outcome Measures Improve the 
Delivery of Person-Centered Diabetes Care? A Review of Recent 
Developments and a Case Study. Published in Current Diabetes Reports. 19, 
9, 18 s., 84. 2019. 
 
SKOVLUND: THE USE OF SYSTEMATIC APPROACHES TO PATIENT INVOLVEMENT IN THE DEVELOPMENT AND 
EVALUATION OF A PATIENT REPORTED OUTCOMES TOOL FOR USE IN ROUTINE DIABETES CARE. 
17 
READING GUIDE 
This thesis consists of five main parts: 
 
CHAPTER 1. INTRODUCTION AND BACKGROUND 
 
In chapter 1 the unique challenges of both living with and managing diabetes as well 
as the need for multi-stakeholder collaboration in the design of a national PRO tool 
aimed at facilitating value-based, person-centered diabetes care are introduced. This 
chapter briefly highlights some of the key methodological frameworks which were 
important for the design of the research studies in the thesis.  
CHAPTER 2: THE DEVELOPMENT OF THE PRO DIABETES TOOL 
 
Chapter 2 provides the necessary context for understanding the role of the three 
studies in this thesis in the broader development of the Danish PRO diabetes 
questionnaire and the digital PRO tool, DiaProfil. The chapter summarizes the key 
steps of the national PRO diabetes development program from 2017-2021 with 
emphasis on the use of systematic methods for patient involvement in each phase by 
the author of this thesis. 
CHAPTER 3: SUMMARY OF THE THREE ORIGINAL STUDIES 
 
Chapter 3 introduces the three studies of the thesis and provides a commentary on 
their aims, methods and key findings.  
  
CHAPTER 4 IMPLICATIONS  
 
Chapter 4 summarizes the key contributions of the research in this thesis and the 
implications for future research and care improvement. 
CHAPTER 5 CONCLUSIONS 
Chapter 5 briefly summarizes the main conclusions of the thesis. 
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CHAPTER 1. INTRODUCTION AND 
BACKGROUND 
1.1. THE CHALLENGE OF LIVING WITH AND MANAGING 
DIABETES  
Diabetes is a lifelong, demanding, self-managed chronic illness which affects multiple 
aspects of life 9. Many People With Diabetes (PWD) experience negative impacts on 
their quality of life and are at high risk of acquiring late-stage complications due to 
gaps in access to coordinated person-centered diabetes care and support and due to 
psychosocial barriers to effective self-management. Extensive research regarding the 
lived experience of PWD and Family Members (FM) demonstrates that living with 
diabetes is often associated with a broad impact on most aspects of life over the course 
of the illness and a need for more support than is provided from traditional health care 
6–12. Both PWD and FM report major impacts and challenges in daily life related to 
diabetes which vary over the life span 6,13–15. 
Depending on the progression of the disease, treatment intensity and modalities 16,17, 
and presence of comorbidities 7, diabetes can impose highly burdensome self-
management demands 18,19, disabling side-effects from treatment 20,21, and affect both 
psychosocial well-being and health related quality of life overall 7,22.  
1.2. THE NEED FOR MULTI-DISCIPLINARY AND WHOLE-
PERSON CENTERED DIABETES CARE 
To improve outcomes for PWD, care services are required which provide 
individualized 23, collaborative, person-centered 5,24,25 and psychosocial 5,7,26–28 
diabetes care as feasible with the available healthcare resources 29,30.  
Many PWD do not receive the level of individualized care and self-management and 
psychosocial support they need to achieve optimal care outcomes 7,31.  While 
numerous strategies and theory-based interventions have been developed for 
empowerment, problem-solving, peer support, self-management, and psychosocial 
support 32–35, the integration of such strategies in standard care that ensures access to 
all PWD has proven extremely challenging 32,34,36–38.   
New feasible tools and strategies are required which can increase active involvement 
of PWD in their own care 5, improve coordination of care from the multi-disciplinary 
team 39 around the full range of needs of the PWD and FM and integrate ongoing self-
management and psychosocial support into the standard diabetes care process 27,40.  
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It is important for future care tools to facilitate inclusion of PWD as equal partners in 
the planning of their own care including the definition of personal care goals 5,41.  
Models for diabetes self-management highlight the multi-faceted role of biological 
factors, health beliefs, self-efficacy, interpersonal care quality, and social 
environmental influences on health behaviors and diabetes outcomes 42. 
Providing information and multi-level support for autonomy and disease mastery to 
PWD and FM so they can be as actively engaged in the management of diabetes as 
they wish should be a key aim of efforts to improve outcomes of diabetes 5,34,43–45. A 
multi-sector, whole-of-society approach to care, health promotion and prevention for 
diabetes is required which reflect the complexity of the illness and the interplay of 
everyday life circumstances, psychosocial, community and societal factors involved 
with diabetes treatment and self-management 46–50. 
The WHO framework for innovative chronic illness care highlights the need for a 
systemic multi-level integrated care approach for chronic illness based on a person-
centered approach that optimizes outcomes for PWD over the life span 39,51.  
There is no single agreed definition of person-centered care or theory for person-
centered diabetes care. The terms are often used to refer to an approach or a paradigm 
of care which acknowledges the priorities, rights, values, and preferences of patients.  
In this thesis, the terms “person-centered care” and “person-centered diabetes care” 
are used this thesis to refer to “care that is organized around understanding and 
meeting the needs, values and preferences of the individual patient and family 
members involved” 52. Person-centered care in this thesis refers to an approach to care 
which puts focus on respectful engagement of PWD and FM as partners using a 
whole-person approach. One of the more widely adopted and supported concrete 
definitions of person-centered care highlights six main dimensions (Institute of 
Medicine Report (IOM) 52: “1.Respect  for  the patients’  values,  preferences,  and  
expressed  needs; 2.Coordination  and  integration  of  care;  3. Information,  
communication,  and education; 4. Physical comfort; 5. Emotional support — 
relieving fear and anxiety;  and  6. Involvement  of  family  and  friends “ 52.  
The concept of person-centered diabetes care used in this thesis is aligned with the 
values outlined by the IOM 52 and is supported by person-centered diabetes research 
undertaken over the past two decades which provide empirical and theoretical support 
for many of the proposed components 5,23. As previously published by the author, 
person-centered diabetes care should, to be true to its foundation on interpersonal 
relations and collaboration, be seen as a dynamic process which involves a continual 
learning cycle fueled by the active involvement of stakeholders across the whole 
support network 5. Key elements of person-centered diabetes care supported by 
research involving PWD and FM as partners include 5:   
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1) Person-centered diabetes communication 53,54. Active listening, empathy, respect, 
sharing and explanation of information, support for autonomy and collaborative care 
represent important components of person-centered diabetes care which are important 
to PWD. General best practice recommendations for person-centered communication 
were defined by King et al as follows: “(1) fostering the relationship, (2) gathering 
information, (3) providing information, (4) making decisions, (5) responding to 
emotions,  and (6) enabling disease- and treatment-related behavior” 53. 
Person-centered communication involves consideration of PWD’s own resources, 
support systems and successes 55 in care and focus on the PWD’s perspective and 
decisions 56.  
2) Care focused on the “whole person”, entails consideration of the overall health and 
life situation of both PWD, their FM and caregivers. This focus takes into account all 
relevant physical, social, psychological and life circumstance factors 5.  
3) Autonomy support and empowerment through both an individual 57,58 and systemic 
approach 5,45 that allows PWD and FM to be able to optimally take an active role in 
the PWD’s own care and self-management in line with their capabilities and 
preferences.  
4) Individualization of health promotion, education, and care goals based on personal 
priorities, values, resources, preferences and needs of PWD and acknowledgement of 
the need for ongoing psychosocial and self-management support as part of care 5. 
Generic models for person-centered care in general practice emphasize the focus on 
“patient preferences, coordination of care, emotional support, access to care. 
continuity, transition, information, education, and family and friends of PWD” 59.  
The DAWN2 (Diabetes Attitudes Wishes and needs) study program defined 
indicators of person-centered diabetes care through an extensive multi-national multi-
stakeholder participatory process 8. The program identified the need for a 
biopsychosocial, social-ecological person-centered model of diabetes care which 
recognizes the significance of social determinants of health for PWD. The 
stakeholder’s concluded that to improve the lives of PWD, diabetes care and education 
must be optimized in context of societal and environmental influences including 
factors such as community and societal support and public awareness 5. 
The DAWN2 studies generated multi-national empirical evidence which pinpointed 
gaps in access to empowering and psychosocial care at individual, HCP, community 
and societal levels 6–12. Multi-level regression analyses were used to identify 
relationships between person-centered care indicators and outcomes 6,10,11 which 
highlighted the importance of delivery of care which treat the whole person rather 
than focuses only on pre-defined clinical and behavioral targets. It was identified that 
care tools and strategies for value based diabetes care should rely on a shared robust 
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understanding of the perspective of PWD 5 and evidence-based recommendations for 
optimal quality diabetes care 23 including strategies for patient engagement 60 and  
psychosocial 27,61 and self-management support 40. New tools should draw on the 
empirical research accumulated across the fields of diabetes psychology, behavioral 
diabetes, clinical and nursing research and the wider PRO and patient engagement 
research fields 60. These approaches and guiding principles to person-centered care 
were considered in the research design of this thesis. 
1.3. USE OF DIGITAL PRO TOOLS TO FACILITATE PERSON-
CENTERED DIABETES CARE 
While attempts to use digital PRO solutions in diabetes care is not new 62,63, the 
maturation of digital capabilities of many health systems today provide new 
opportunities for seamless integration of PRO tools in routine care in order to support 
key components of person-centered diabetes care such as empowerment, collaborative 
care, psychosocial care, and self-management support 2,4.  
The consistent evaluation of each PWD’s needs, priorities and preferences from a 
“biopsychosocial” perspective, as recommended for person-centered diabetes care 
23,24, is difficult to do within the constraints of regular practice. The availability of 
digital PRO tools may facilitate more consistent monitoring of subjective indicators 
4. 
Digital app and web patient platforms which combine multiple data sources may 
facilitate aspects of individualized behavior change and cognitive theory-based 
support through monitoring of individual goals, barriers, preferences, resources, and 
results 64–66. PRO tools, such as the Danish PRO diabetes tool, may play an important 
role by incorporating interpersonal relations, access to care, community and social 
support sources, general life challenges affecting diabetes, and care navigation. 
An important diabetes-specific, empirically based operationalization of a key 
component of person-centered diabetes care relevant to the theoretical basis for use of 
PRO in diabetes is referred to as diabetes empowerment.  
The diabetes-specific empowerment model developed by M. Funnell and R. Anderson 
57 describe empowerment as a process and outcome of diabetes care with focus on the 
individual PWD. This model highlights the importance of the PWD feeling ownership 
of the process of learning about how diabetes impacts life, defining personal priorities 
and preferences for his or her own role, and being able to manage diabetes 67. 
The use of the model initially focused on how HCP can facilitate empowerment. 
Methods such as guided self-determination have been developed in order to try to 
provide tools for HCP and PWD to help overcome critical barriers to implementing 
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empowerment in routine diabetes care 58.   
This thesis discusses that the use of a digital PRO diabetes tool may facilitate aspects 
of individual empowerment by increasing self-reflection, expression of the PWD’s 
own preferences and needs, active collaborative care planning and patient-led 
experimentation to improve patient-important outcomes 68,69. A broader approach to 
empowerment emphasizes the importance of support from HCP, social relations, 
community, and civil society in making the PWD capable of engaging as an 
empowered and health literate “patient” 5. The term “health-related empowerment” 
has been proposed to cover a broad concept of empowerment related to health literacy, 
self-awareness and capacity for collaborative care, self-efficacy and self-management 
support, the environment and opportunities for action 45. Other research supports the 
importance of considering resilience and healthcare, social relations, and society at 
large for helping people live well and healthfully with diabetes 5,70.  
PRO tools should reflect that PWD and FM depend on support at multiple levels to 
manage the PWD’s diabetes: individual management and coping, family and social 
relations, context of everyday life, and culture and society 71,72.  Digital PRO tools to 
enable person-centered diabetes care should reflect the importance of HCPs and 
different health sectors working together to empower PWD to improve patient-
important outcomes over the lifespan.  Social determinants of health have been 
categorized into the following categories: “1) individual lifestyle factors, 2) social and 
community networks, 3) Living and working conditions, 4) general socio-economic, 
cultural and environmental conditions and 5) virtual world, information and 
communication technologies” 73. While these do not represent outcomes, they should 
be considered in PRO tool design to ensure any relevant factors are incorporated to 
ensure a broadly unifying outcome measure and equitable health impact. 
A social-ecological model allows for the required analysis of interactions between 
individual, healthcare, community and environmental factors as they influence the use 
and impact of PRO tools in routine care to improve health-related empowerment and 
outcomes 5,46,71,74. A “whole of society” approach to the organization of the design 
process for PRO tools is key to improve care in an equitable way 49 which ties 
empowerment, healthcare access, community support, and societal policy for better 
health together.  
1.4. HEALTH OUTCOMES MEASUREMENT 
The field of health outcomes measurement originates from the requirements of the 
public health and clinical research fields to develop reliable, valid methods for 
assessment of individual health status and related outcomes. Several outcomes 
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taxonomies exist and a generic taxonomy of health outcomes has been proposed based 
on systematic review of trial research and includes 6 main categories of outcomes 75: 
“1) Mortality,  2) Physiological or clinical outcomes, 3) Life impact: Global quality 
of life, perceived health status, emotional functioning and wellbeing, physical, social, 
cognitive functioning, 4) Experience of care, including  satisfaction, patient 
preference, acceptability, availability, self-management, withdrawal from treatment, 
appropriateness of treatment, process, implementation and service outcomes,  and 
personal circumstances, 5) Resource use: Economic, hospitalization, caregiver 
burden, societal burden, and 6) Adverse events” 75. 
This generic outcome taxonomy does not describe how to measure or weigh the 
individual outcomes or what outcome components are important for a particular 
disease from the perspective of people living with the condition or their caregivers. 
The term patient-important outcomes has been used to refer to outcomes with an 
assumed direct impact on the patient’s quality of life 76,77. This concept differs, 
however, from outcomes determined to be person-centered as a result of systematic 
involvement of patients in their selection and definition. The assessment of the 
subjective impact of diabetes on functioning and well-being has been found to be 
important for decades, but subjective outcome indicators have rarely been used 
systematically 78–80. 
Disease-specific outcome models are developed from extensive qualitative and 
quantitative empirical data from the target population with the aim of providing an 
informative and comprehensive picture of the outcomes relevant for the given disease 
and target group in accordance with the intended use of the outcomes. The scope and 
extent of health outcomes models therefore vary considerably based on the purpose 
and origin of the model, its theoretical underpinning, and intended use. 
The term HRQOL (HRQOL) refers to the patient’s appraisal of their current level of 
functioning, well-being and satisfaction specifically related to their health condition 
or treatment 81,82. The majority of PRO questionnaires referred to as disease-specific 
quality of life instruments assess outcome constructs related to life impact, and 
treatment experience which is reflected in the outcomes taxonomy 75,82.  
Outcome of diabetes care has historically been assessed predominantly by using 
clinical and physiological outcome indicators with limited measurement of outcome 
domains pertaining to direct impact 76 and subjective life impact 80. Prior to study I in 
this thesis, there was no national quality assessment program that aimed at evaluating 
subjectively assessed life impacts of diabetes which appropriately reflect patient-
important outcome domains as well as the values of person-centered diabetes care. 
Study I of this thesis aims at defining an outcomes model for diabetes which builds 
on 1) empirical data regarding the multi-faceted subjective impact of diabetes on 
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physical, psychological and social aspects functioning and well-being 7, 2) 
perspectives and preferences of PWD and FM for outcomes assessment,  and 3) 
evidence of complementarity of PRO data to physiological and clinical data 83. 
1.5. VALUE-BASED HEALTH CARE AND OUTCOMES 
EVALUATION  
The value-based healthcare (VBHC) framework designed by Michael Porter proposes 
that implementation of systematic measurement of core patient-important outcomes 
across health sectors is a key first step for driving improvement in health value and 
outcomes over the lifespan 48,84. The hierarchy of health outcomes as it was originally 
proposed for use for value based healthcare includes the following three key tiers:  
Tier 1) Survival, health status and degree of health or recovery  
Tier 2) Process of recovery and disutility of the care process  
Tier 3) Factors for sustainability of health 85.  
The hierarchy of health outcomes was used in study I to guide the definition of a core 
set of patient-important diabetes outcome constructs for use for diabetes care in 
Denmark 1. The VBHC outcomes framework was also recently used in the 
development of the first global outcome measurement standards for diabetes of the 
International Consortium for Health Outcomes Measurement (ICHOM) 86. 
1.6. METHODS FOR DEFINING CORE HEALTH OUTCOME SETS  
Harmonization of outcomes and indicators used across health care settings and 
countries for a specific disease is desirable as it facilitates benchmarking, efficiency 
of research and knowledge sharing 87,88.  The pursuit of “Outcome Sets (COS) or 
agreed standardized set of outcomes” which are agreed upon to be measured and 
reported as a minimum in all outcome evaluations for a given disease can be important 
for comparative research and scientific exchange 89,90. The use of standardized 
outcomes can have important benefits for population-based quality improvement91 
and for setting comparative standards for clinical trial data regarding new medicines 
and medical devices. Key steps for development of a COS used in study I include 1) 
scope specification (setting, population, intervention), 2) stakeholder involvement 
(patients, HCP and researchers), and 3) consensus process (balancing views of 
patients and HCP, pre-defined criteria and process for selection) 87. Specific methods 
to develop core outcome sets include consensus meetings, the Delphi method, the 
nominal group technique, surveys, systematic literature reviews, semi-structured 
discussions, and multi-stakeholder working meetings 89,92–95.  
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1.7. DIABETES SPECIFIC CORE OUTCOME SETS 
Study I in this thesis focuses on the definition of a core set of outcome constructs for 
specific use in routine diabetes care. This answers the question of “what” should be 
measured, i.e. “what constructs are important and value-adding to measure?” The 
subsequent question of “how” to measure the identified constructs reliably and validly 
in practice in order to allow for reliable monitoring and benchmarking is a separate 
process involving psychometric methods to establish reliability and validity.  
At the time of study I, there was no international consensus regarding which PRO 
constructs should be measured as core outcomes in diabetes alongside clinical 
outcomes. There was also no agreement about which generic and diabetes-specific 
PRO questionnaires should be consistently used in either clinical trials or quality 
monitoring in diabetes in order to facilitate comparability and benchmarking 96.  
A recent review of outcomes used in 132 clinical diabetes trials found there was a 
combined use of more than a 1000 different outcome indicators 88 which highlights 
the need to identify core sets of outcome indicators for people with type 1 97 and type 
2 86 diabetes in order to enable consistent outcomes assessment across settings 84.  
Given the complex interactions that exist between outcome indicators and other 
factors such as socioeconomic status and co-morbidities, a set of case-mix variables 
must be defined based on clinical and statistical evidence so they can be considered 
in outcome analyses intended for benchmarking to ensure correct interpretation 86.  
1.8. PRO RESEARCH METHODOLOGY 
Evidence-based standards for the development and psychometric evaluation of PRO 
questionnaires (PROM) to optimize acceptability, content validity, reliability, 
responsiveness and utility have been developed based on extensive empirical research 
and measurement science 93,98–100.  The increasing use of PRO in clinical trials for 
medicines and technologies has facilitated the emergence of detailed and stringent 
standards for development and documentation of PROMs for trial research 101,102. 
Both traditional and modern psychometric methods are used for questionnaire design 
as well as adaptation and assessment of validity, reliability, scoring and interpretation 
99,102,103.  
1.8.1. TYPES OF PRO QUESTIONNAIRES 
PRO questionnaires are designed to collect direct reports from the patient regarding 
the subjective experience of health, health related constructs, and treatment. These 
questionnaires are used to assess health outcome indicators which can only be 
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assessed through direct report of the patient and complement outcome indicators 
assessing clinical or electronic comprehensive health outcomes assessments.  
Patient Reported Outcome Measures (PROM) can be categorized according to 
whether they measure health perceptions, functional status, well-being, symptoms, 
HRQOL, treatment experience and satisfaction, and other health related constructs104. 
Other health-related constructs might include measures of health behavior, self-
efficacy, health beliefs, resilience, support systems, resources, and health-related 
environmental factors. There is limited consistency in how PRO questionnaires are 
classified in the literature today. Some questionnaires are referred to as self-reported 
health status or HRQOL depending on the research team. Some psychometric clinical 
questionnaires referred to as PROMs include content that can be categorized as 
“Patient Reported Inputs” (PRI) 4, which include topics such as motivational drivers 
105, treatment beliefs and attitudes 106, care and education preferences, and personal 
goals 4.  
Questionnaires may use Likert scaling, visual analogue scaling, pictorial charts, 
animation, and other methods and use global rating items or multi-item scales with 
each method having its unique benefits and disadvantages 107. 
PRO questionnaires may be developed solely by professionals, or co-developed to 
varying degrees with patients90. They may measure patient-relevant or patient 
irrelevant outcome constructs 108. Thus, PRO questionnaires — like clinical outcome 
methods — may or may not be suitable for patient-centered outcome assessment. 
PRO questionnaires may be generic or disease-specific and designed for: evaluative 
use, clinical use (screening, dialogue, care planning, shared decision-making), 
epidemiologic research, quality of care monitoring, and research purposes 15.  
1.8.2. DEVELOPMENT OF PRO QUESTIONNAIRES 
Key overall steps for development of PROMs include 1) Literature review, qualitative 
research and establishment of core constructs, a conceptual model and a measurement 
model, 2) Design of the questionnaire with patients and HCP to achieve the desired 
psychometric properties (validity, reliability, responsiveness, interpretability), and 3) 
Psychometric assessment of measurement properties based on sufficiently large 
patient sample to verify, modify, and finalize the PROM with patients and HCP. 
4,16,102,109. The quantitative assessment of measurement validity after collaborative 
development and the adjustment of the questionnaire in accordance with the 
psychometric analyses represent an important yet often overlooked step due to time 
and resource demands. Development of a PROM requires that systematic review of 
the literature is undertaken in advance of questionnaire development with explicit 
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consideration of both qualitative 110 and quantitative 101 empirical data. Qualitative 
research utilizing interviews, focus groups, surveys and other data is required for 
developing the iterative psychometric design with the participation of both patients 
and HCP using patient-centered quality criteria for each phase of the questionnaire 
design and validation 4,90,99,102.  
1.8.3. PSYCHOMETRIC QUALITIES OF PRO QUESTIONNAIRES 
Four main categories of psychometric assessment are often used when developing and 
evaluating a PROM: validity, reliability, responsiveness and interpretability101,111.  
A systematic empirical and analytical process is required to establish content validity 
of a PRO questionnaire 98. Content validity includes face, construct, known-groups, 
and criterion (concurrent and predictive) validity. It also often encompasses cross-
cultural validity when questionnaires are adapted from other languages. Assessment 
of reliability involves assessment of internal consistency, inter-rater reliability, 
measurement error and test-retest reliability 112.  
Responsiveness refers to the extent to which a PRO questionnaire can quantify 
differences in the latent construct being measured over time or in response to an 
intervention 99. Interpretability is essential for the effective clinical use of PRO results. 
Distribution and anchor-based methods for assessing the minimal clinically important 
difference (MCID) 113 are both important to facilitate interpretability of PRO scores 
for clinical and evaluative use 113–116. Detailed guidance for clinical interpretation of 
change scores require quantitative and qualitative analysis as multiple factors may be 
involved with complex interrelationships 116. 
Since responsiveness and interpretability are critical to clinical utility and patient 
benefit, it is important to elicit patient preferences for interpretability early in the 
process. Patients may prefer simple and transparent scoring methods, as we found in 
the Danish PRO diabetes program or may accept complex item-response-theory (IRT) 
based scoring methods such as those used in the Swedish PRO diabetes program 
117,118. 
Patient’s perceptions of relevance and clinical utility is important during design to 
optimize usability of the PRO tool in routine care. Patient’s perspectives on relevance, 
acceptability, responsiveness, and interpretability of status and change scores is an 
important part of the iterative design of questionnaire content and format.  
1.9. DIABETES-SPECIFIC PRO RESEARCH 
The assessment of HRQOL, psychological well-being and treatment satisfaction has 
been acknowledged as clinically relevant in diabetes for decades based on the role 
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psychosocial factors and self-management play in diabetes care 28,78. Some of the first 
large-scale clinical diabetes trials to use PRO were the landmark Diabetes Control and 
Complications Trial (DCCT) 119 and UK Prospective Diabetes Study (UKPDS) 120 
studies. In these studies, PRO questionnaires were included for longitudinal 
evaluation of self-reported health and quality of life alongside clinical outcome 
indicators. In the DCCT, the Diabetes-specific Quality of Life Questionnaire (DQOL) 
119 was used to measure three domains: diabetes impact, diabetes worry and diabetes 
satisfaction. Follow-up studies also used generic health utility questionnaires 120. The 
study reported that diabetes complications were associated with impaired quality of 
life whereas there was no significant impact of intensive therapy vs. conventional 
therapy on quality of life 119,120. The UKPDS used the generic EuroQol (EQ-5D) and 
reported no direct impact of intensive blood glucose-lowering therapy on PRO 
outcomes. Hypoglycemia was however associated with negative impacts on self-
reported indicators of quality of life 121. Since these studies were completed, more 
diabetes-specific PROMs have been developed with input from PWD and have been 
used to show that diabetes treatments impact diabetes-related quality of life 
15,19,78,79,122,123 and related PRO constructs differently 124–126. There are many factors 
influencing quality of life and perceived impact of diabetes apart from medical 
treatment 11 which makes standardization and interpretation of PRO diabetes data 
difficult. Empirical research supports the importance of complementing clinical 
outcomes with subjective assessments of perceived impact of diabetes on physical, 
psychological, social functioning and wellbeing 15,19,78,79. Self-reported assessment of 
physical health and symptoms is for example an independent predictor of prognosis 
and hospitalization in diabetes 83.  
Hundreds of generic and diabetes-specific PRO questionnaires have been used in 
academic diabetes research and to a lesser extent in care improvement programs 
during the past decades 4,79,123,127,128.   
Generic self-reported health and HRQOL instruments are often used PRO to evaluate 
outcomes in diabetes 121,129,130, yet diabetes-specific questionnaires are often required 
to achieve sufficient specificity and sensitivity 15,123. The majority of diabetes PROMs 
published today adopt a reflective measurement model and aim to measure 
unidimensional latent constructs 117,131.  
Diabetes PRO questionnaires are developed for a wide variety of purposes and span 
clinical screening instruments, treatment monitoring, clinical evaluative instruments, 
quality of care  assessment, health psychological research tools 7,12,19,80,122,127,132–137. 
PRO instruments reflect different theoretical constructs including self-reported health 
and daily functioning, mental health constructs, well-being, quality of life, diabetes-
related quality of life, barriers and resources for living well with and self-managing 
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diabetes, satisfaction with diabetes treatment, confidence in self-management, 
experience of support, and access to quality person-centered care4,79,133. Versions of 
diabetes PROMs have also been developed for completion by FM 4,12,135,138.   
To explain the perspective of the author of this thesis for reflexivity purposes, the next 
section outlines PROMs for diabetes which were psychometrically developed or 
adapted by the author in previous research. The list reflects the author’s foundation in 
empirical research related to the assessment of both traditional health and quality of 
life outcomes, measures of person-centered care experience, and health-related 
constructs such as self-management, empowerment, health, and treatment beliefs as 
well as broader supports and barriers to care. All these factors are relevant in the 
consideration of how to involve PWD and FM in the design of a PRO tool for clinical 
use. The author co-developed or adapted the following measures prior to the research 
in this thesis: 1) Perceived impact of diabetes on life (Impact of Diabetes Profile 
(DIDP 7,8,122), 2) Diabetes related distress (PAID-5, PAID-1 137), 3) Impact of diabetes 
on quality of life in youth with diabetes (MY-Q 135), 4) Diabetes Quality of Life in 
Youth Short Form Questionnaire (DQOLY-SF 139), 5) Diabetes Medication 
Satisfaction Questionnaire (Diab-MedSat 19), 6) Insulin Treatment Satisfaction 
Questionnaire (ITSQ 16), 7) Global Satisfaction with Diabetes Treatment 
Questionnaire (GSDT 134), 8) Short Form of the Summary of Diabetes Self-Care 
Activities Assessment (SDSCA-SF 7), 9) DAWN Short Form of the Diabetes 
Empowerment Scale (DES-DSF 8), 10) DAWN Family Support Scale (DFSS 8), 11) 
Support For Diabetes Self-management Scale (DSDSP 8), 12) Perceived Support For 
Diabetes Scale (PSS114), 13) DAWN Short-Form health-care climate questionnaire 
(HCC-DSF8), 14) Insulin Treatment Appraisal scale (ITAS 106,136,140), 15) Short-form 
Patient Assessment of Person-centered Chronic Illness Care (PACIC-DSF8), 16) 
Barriers to Medicine Scale (BM 134), 17) Diabetes Symptom Measure (DSM 19), and 
18) Impact of diabetes on productivity (Diabetes Productive Measure 19). The author 
also developed psychometric questionnaires for completion by family members of 
PWD 12,138, HCP 138,141, and co-developed multi-dimensional PRO diabetes 
questionnaires for clinical use 135,142 to support delivery of person-centered diabetes 
care. The author applied PRO questionnaires in diabetes relating to generic health 
(EuroQoL 7, SF-12 134), generic quality of life (WHO-QOL-BREF 8, WHO-5 28,62,142–
144), and diabetes-specific quality of assessment (DSQOLS 145).  
The author collected qualitative insights into the perspectives of PWD and FM 
through the use of qualitative research methods (i.e. focus groups, interviews) 16,19,146, 
scale reduction methods137,139, psychometric evaluation methods16,19, and 
participatory research methods 8,135 in the development of PROMs.  
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1.10. SPECIFIC METHODS FOR DESIGN OF PRO FOR CLINICAL 
USE 
The development of a PRO questionnaire for use in routine care requires that both its 
psychometric qualities and its functionality is optimized for its clinical purpose 
4,109,147. Standardized steps for design of a PRO for clinical use can include 148 (1) 
identifying the goals for collecting PROs in clinical practice, (2) selecting the patient 
target group, setting, and timing of assessments, (3) determining which 
questionnaire(s) to use, (4) choosing a mode for administering and scoring the 
questionnaire, (5) designing processes for reporting results, (6) identifying aids to 
facilitate score interpretation, (7) developing strategies for responding to issues 
identified by the questionnaires, and (8) evaluating the impact of the PRO intervention 
on the practice.  
A PRO tool may be based on one 143,149 or multiple theoretical models 4 and as is the 
case with the Danish PRO diabetes questionnaire which contains a combination of 
PRO constructs that originated from different empirical or theoretical foundations. 
Each subcomponent of the PRO diabetes questionnaire should be psychometrically 
assessed in accordance with the specific intended use of the specific item or multi-
item scale score. For example, a multi-item scale to measure psychological well-being 
as an outcome must have adequate reliability, validity, and responsiveness to be able 
to reliably monitor well-being over time and with adequate responsiveness to 
intervention effects, whereas certain global items intended for screening and dialogue 
use may not need to be able to detect and quantify changes over time. Different design 
approaches are used for PRO tools depending on their scope and may include user-
centered design 150,151, theoretical models for behavior change 152, and frameworks to 
optimize public health impact 153.  
1.11. PATIENT INVOLVEMENT IN DESIGN OF CLINICAL PRO 
TOOLS  
Systematic patient involvement and multi-stakeholder participation is required in each 
step of development of a PRO questionnaire for clinical use. This is important to 
ensure the questionnaire obtains adequate psychometric characteristics and other 
design features in accordance with the intended use of the PRO tool 4,90,108,148,154–157. 
An iterative, participatory design process is required in the development of PRO 
questionnaires which ensures detailed patient perspectives are reliably obtained and 
considered in relation to face validity, relevance, acceptability, appropriateness, 
interpretability, responsiveness, reliability, validity, implementation and public health 
impact optimization.  
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The author of this thesis developed a stepwise approach to patient involvement in the 
development of the Danish PRO diabetes questionnaire which is outlined in table 2.  
The three studies in the thesis represent examples of specific elements of the larger 
research program for patient involvement in the Danish PRO diabetes program. 
Research using data generated from this thesis to evaluate the value of patient 
involvement strategies for the PRO diabetes tool at each stage in order to provide 
guidance for how to prioritize strategies in future PRO research programs is ongoing. 
1.12. QUALITATIVE METHODS USED FOR PATIENT 
INVOLVEMENT IN PRO RESEARCH 
Qualitative health research methods, referred to here as the “collection and systematic 
analysis of non-quantitative data about peoples’ experiences related to their health” 
158, can be used and adapted in pragmatic ways to facilitate representation, rigor, 
transferability, and credibility of the patient involvement process in PRO 159. 
Qualitative research methods such as participant validation, thick description, 
representation analysis, saturation, comparative analysis, and reflexivity can be 
adapted to improve the patient involvement process and its impact 158. Qualitative 
research is used to strengthen integration of the lived experience of the disease 110 in 
different phases of PRO instrument development, evaluation, and implementation 
90,160. Qualitative research is used in medical and psychological intervention research 
to ensure solutions and evaluations reflect and are enhanced by a deeply nuanced 
understanding of the perspective and values of both patients and family members. 
These purposes align with the core intentions of patient involvement in the 
development of the PRO diabetes solution 90. As ambition levels for and requirements 
to patient involvement increase in diabetes research, the need for rigorous systematic 
methods to document and report the quality and effectiveness of the patient 
involvement process increases 161. The ambition to include more patients in research 
as well as use digital tools to engage patients creates a need for systematic qualitative 
research methods for collection and analysis of large amounts of data.  
It is important to distinguish traditional qualitative research (where the patients are 
research subjects) from involvement of patients as contributors, partners and co-
designers of the research design. In this thesis, patient involvement in research refers 
to the involvement of patients as partners in the research design.  
While the use of qualitative research is a necessary part of PRO questionnaire 
development 98,162 and can be integral to effective patient involvement, the majority 
of PROMs today were developed without documentation of how patients were 
involved as partners at each stage of development of the PRO 90,163.  
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In this thesis, qualitative analysis methods were used to augment the process of patient 
and stakeholder involvement in the PRO diabetes development process in order to: 
(1) more accurately and reliably elicit, document and consider both patients’ and 
caregivers perspectives and experiences at each phase of planning, undertaking and 
reporting of research studies;  
(2) ensure that divergent patient perspectives and important contextual factors are 
sufficiently documented to provide transparency regarding diversity and 
representativeness of input and potential biases.  
(3) allow for the ongoing quality assurance and evaluation of the process quality of 
involvement as well as examine indicators of effectiveness and impact of patient 
involvement on the research aims. 
1.13. USE OF MIXED-METHODS IN CLINICAL PRO RESEARCH 
Mixed methods research, which combines both a quantitative and a qualitative 
research component 164,165, is a relevant methodological approach when the 
combination of quantitative and qualitative methods are expected to result in a better 
research outcome than if the qualitative and quantitative studies are done separately 
165. Mixed methods are often applied in a pragmatic framework with a focus on 
flexible and appropriate use of multiple methods to achieve the best possible research 
outcome 166. Mixed methods research has been highlighted as particularly valuable 
for use in clinical PRO research due to the complexity of the design, implementation, 
and evaluation of PRO in clinical practice 159.  
1.14. MULTI-STAKEHOLDER PARTICIPATION IN PRO DESIGN 
Design of PRO tools for clinical use require multi-stakeholder participation in all 
phases using strategies that ensure effective participation, co-learning and 
collaboration of all the main stakeholder groups 167–170. Planned strategies are required 
to ensure all relevant stakeholders (i.e. primarily patient. professional users, payers,  
and direct beneficiaries) are actively involved in the preparatory, execution, and 
application phases of the research program 168,171. For the purpose of this thesis, the 
term “participatory research” is used to denote that explicit actions are taken to ensure 
practice-based inclusion of the relevant stakeholders in all the phases of the project.  
Multi-stakeholder participation is required to achieve a sustainable clinical PRO 
solution with a high potential for adoption, implementation, and public health impact. 
Multi-stakeholder participation is addressed in this thesis because it is hypothesized 
that for patient involvement to be most effective, patients must be involved as an 
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integral part of a multi-stakeholder participatory process which allows for mutual 
learning and exchange among PWD and professionals. The participatory strategies 
applied in this thesis to improve the research and to support the effect of systematic 
patient involvement activities in the development of the PRO diabetes tool are shown 
in table 4. The strategies focus on the significance of creating a respectful, trusting 
research environment which is conducive to effective mutual learning. The aim is to 
achieve an inclusive form of inquiry with a focus on enabling active participation of 
all involved stakeholders in each phase of the research. The aim with the applied 
participatory approach in this thesis is for patients to be involved on equal terms with 
other stakeholders to identify and address individual, health care, community, 
contextual and policy factors, which can influence the achievement of the project’s 
patient-centered outcome goals172. 
 
1.15. PATIENT INVOLVEMENT IN RESEARCH 
Patient involvement in research in this thesis refers to the involvement of patients as 
collaborators, i.e. active agents, in the research process to help guide the research 
process itself and part-taking in shaping the definition of aims, design the protocols, 
build the intervention, plan the analysis and application and dissemination of results. 
Patient involvement is used to refer to health research which is carried out with or by 
members of the public or patients rather than to, about or for them. It occurs “when 
patients meaningfully and actively collaborate in the governance, priority setting, and 
conduct of research, as well as in summarizing, distributing, sharing, and applying its 
resulting knowledge (i.e., the process referred to as ‘knowledge translation’)” 173. 
Many alternative terms are used to reflect patient involvement including public-
patient involvement (PPI), patent engagement, patient involvement, patient 
partnering, user involvement, service user involvement, patient-centered,  and patient-
orientated research. The involvement of patients, the explicit elicitation and use of 
experiences, perspectives, and preferences of patients and their families is an 
important part of health research whether it is focused on improvements in medical 
care, organization of care systems, or quality of care improvement 60, or broader 
research 174. In this thesis, a theoretical approach to patient involvement is used which 
is based on the hypothesis that incorporation of the lived experience and perspectives 
of the end users in the research process can help improve research relevance, 
appropriateness, efficiency, and impact potential of research outputs 175,176. Patient 
involvement is also included in research from a rights perspective, i.e. that patients 
and the public have the right to be involved in research which affects the civil society. 
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Involving patients and the public as partners in health research provides an important 
opportunity to leverage the knowledge, skills, and experience of both researchers and 
clinicians as well as of patients and families in collaborating more effectively towards 
making the research more relevant for all. This involvement drives meaningful change 
in how research can become more beneficial for patients and society 176,177.  It is 
hypothesized that patient involvement in health research will increase focus on the 
research questions which are of greatest value to the patients (priority setting) 176. The 
nature of the research and purpose of involvement determines the significance of 
involvement of patients and or the public 178.  
Health and PRO research studies adopt different models for patient participation 
ranging from tokenism, highly limited ad hoc, or retrospective consultation with 
individual patients to engagement of patients as partners or leaders of projects. A 
single health research study often utilizes several types of patient involvement 
depending on the research phase, participants, and purposes of participation 172. The 
different ambition levels for patient involvement in health research studies research 
can be illustrated by 5 distinct approaches to involving the patient: 1) Inform, 2) 
Consult, 3) Involve, 4) Collaborate, and 5) Empower 172 (or user-driven).   
In the systematic approach to patient involvement presented in this thesis patients 
were involved in multiple capacities depending on the specific objectives and research 
questions being addressed at each stage of the process. This was done taking into 
account time and resource constraints. Criteria for theoretical purposive recruitment 
for patient collaborators and partners as well as strategies for education, training and 
engagement of patients were tailored based on the intended type of involvement. 
The term “patient involvement” is not used in this thesis to denote the ambition level 
of involvement but to denote the engagement, participation collaboration, or 
partnership with patients 176. While the author of the thesis believes it is relevant and 
important to pursue patient leadership of projects in PRO research 179, research in this 
thesis uses a collaborative approach to patient involvement as this was what was 
feasible with the available project resources. 
In this thesis, systematic approaches to patient involvement refers to the use of explicit 
advance planning of patient involvement with clarity about the patient’s roles at each 
research stage as well as the methods used to partner with patients to achieve each of 
the pre-specified objectives of patient involvement.  
Systematic patient involvement as the term is used in this thesis refers to patient 
involvement being done in a structured, pre-planned prospective manner with 
specification of methods and objectives for each research phase in contrast to 
involvement being done ad hoc and retrospectively. The term “systematic approach 
to patient involvement” is not used here to imply an extensive resource-demanding 
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comprehensive set of activities as research resources are often limited. A core feature 
of systematic patient involvement as proposed in this thesis is that patient input is 
applied in all stages, including at the first stage where patient-centered goals for the 
PRO tool are co-designed with and endorsed by all involved stakeholders. The 
establishment of a clear patient-centered measurable objective 5 with use of the PRO 
tool represents an important aspect of a patient-oriented, systematic approach to 
patient involvement in PRO 180.  Key patient-centered outcome goals for clinical PRO 
tools can be improvements in care experience, community support, health, and quality 
of life outcomes 4,5.  
1.15.1. FRAMEWORKS FOR PATIENT INVOLVEMENT IN RESEARCH 
Several methodological frameworks exist for how to involve patients in research 
171,172,175,181,182. Hypothesized benefits include enhanced research quality and 
appropriateness including benefits to research prioritization, optimizing relevance and 
applicability of research, efficiency of the research process, and dissemination 183.  
A core feature of systematic patient involvement is that patient involvement is 
initiated early and across all phases. These phases are 1) Identification and 
prioritization of topics and focus for research, 2) Design of the research approach, 3) 
Development of the study protocol and methods, 4) The undertaking/management of 
the research, 5) Analysis/interpretation, 6) Dissemination of results, 7) 
Implementation of results, and  8) Monitoring and evaluation of implementation 175.   
While there are a growing number of patient involvement guidelines and templates 
161,168,184,185, there is no single methodology for patient involvement which has been 
internationally adopted as a standard and the scientific evidence-base for what 
methods work best remains very limited 161,175.  Most frameworks rely on best practice 
mapping rather than empirical evidence and theory while some frameworks 
recommend the creation of purpose-built patient involvement strategies with 
participants due to the intricate and unique nature of each research program and the 
relationship with patients 181. There are ample best practice frameworks to rely on to 
guide patient involvement process quality 181, execution 175 and reporting 161,181,186. 
The author co-developed the global “Patient Engagement Quality Guidance” (PEQG) 
using 3 steps: 1) A collaborative multi-stakeholder process, 2) Review and synthesis 
of international methodological frameworks for patient involvement and 3) Mapping 
and analysis of international best practice cases for patient involvement to iteratively 
design operational quality criteria 181. The resulting guidance is flexible and non-
prescriptive and can be used as an aid to design the patient involvement protocols175.  
Operational descriptions, practical tools, templates, and a database of case studies 
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with best practices were developed for each of the seven quality criteria as part of the 
PEQG to inspire planning and evaluation of patient involvement in health research175. 
For this thesis, the author worked with PWD to apply the PEQG quality criteria (table 
3) in the patient involvement protocols for the Danish PRO diabetes development 
program and undertook a study to evaluate their value. 
1.16. PATIENT INVOLVEMENT IN DIABETES RESEARCH 
Involvement of PWD in diabetes research, care and policy has been in focus for many 
years and experiences are beginning to emerge regarding the value it brings 176. There 
is general consensus that involvement of PWD should be prioritized at all levels: 
individuals, families, health care, community and civil society, and policy 5. The 
author of this thesis has previously designed patient involvement as part of 
participatory multi-stakeholder person-centered diabetes research 5,29,30,135,187. Despite 
a trend towards more focus on patient involvement in diabetes research and care, 
methodological approaches and reporting are not standardized in the literature and 
further methodological and theoretical research is warranted 176. 
1.17. A PUBLIC HEALTH IMPACT MODEL FOR CLINICAL USE 
OF PRO  
The RE-AIM (Reach, efficacy, adoption, implementation and maintenance) model 
was developed to provide an operational framework to optimize and evaluate the 
public health impact of health interventions, such as an office-based digital PRO 
intervention 63. RE-AIM has been used to design or evaluate diabetes interventions 
63,188–191 and diabetes PRO tools 153,192. The RE-AIM model was used to guide research 
in this thesis and specifically the evaluation design in study III 3.  
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CHAPTER 2. DESIGN OF THE DANISH 
PRO DIABETES TOOL FROM 2017-2021  
The three studies in this thesis (appendices I-III) are components of a broader set of 
research activities for development of the national PRO diabetes questionnaire and 
the digital dialogue tool, DiaProfil, which was overseen by the author. The aim of this 
section is to provide the reader with the overall context and to clarify how each of the 
three studies fit into the overall PRO tool development. The section provides a 
chronological overview of the development of the PRO diabetes questionnaire and 
digital tool from 2017-2021 and illustrates the use of systematic patient involvement 
at each stage.  
Figure 1 provides an overview of the development of the PRO diabetes tool from 
2017-2021. The first phase was an analysis and scoping phase in 2017 which also 
included definition of patient-important outcomes (study III). The second phase was 
the participatory creation of the PRO diabetes questionnaire through a series of multi-
stakeholder and patient workshops in 2018. The third phase was finalization of the 
clinical digital tool, DiaProfil. The formative evaluation of DiaProfil occurred in 2019 
(study II), and the fourth phase was design of the national pilot study in 2020 (study 
III).  Table 1 shows the studies and articles undertaken or planned by the author of 
this thesis to clarify the context of the four papers that are included in this thesis.  
2.1. CHRONOLOGICAL OVERVIEW OF THE RESEARCH 
In the fall of 2017, initial literature review, scoping analysis and study I was 
undertaken. We engaged a broad group of PWD and FM from the diabetes community 
in Aalborg, Denmark to discuss the scope and aims of the national project for value-
based diabetes care and identify patient-important diabetes outcomes. In November 
2017 consensus was established to incorporate PRO constructs in the core outcomes 
set for use for value-based diabetes care in Denmark.   
During 2018, the Danish PRO diabetes questionnaire was developed through a 
national collaborative multi-stakeholder process with systematic involvement of 
PWD in all steps. A series of carefully planned patient and multi-stakeholder 
workshops (figure 1) were undertaken to ensure detailed inputs and co-learning for 
each step of the PRO development process.  
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During 2018 and early 2019, the author oversaw the development of the new digital 
PRO diabetes tool, DiaProfil, which used a user-centered design approach involving 
a user panel of PWD, a multi-disciplinary clinical diabetes care team and an IT 
partner.  
In spring 2019, the first pilot evaluation of the feasibility and acceptability of the first 
viable digital PRO tool was done in routine outpatient diabetes visits (study II). 
In the fall of 2019, a longitudinal clinical study of the use of the PRO diabetes tool in 
a hospital setting was initiated (papers X-XII), and study III (a multi-center pilot study 
(M-PRODIA)) was designed to evaluate use of the PRO diabetes tool in different 
health sectors and regions in Denmark. A secondary aim of the study was to collect 
PRO data to characterize construct validity and other psychometric characteristics of 
the PRO diabetes questionnaire and it’s scoring algorithms.  
From December 2019- December 2020, data collection for the M-PRODIA study was 
completed as part of the national pilot testing of the PRO diabetes tool under the 
auspices of the Danish Health Data Authority. Covid-19 caused delays in recruitment 
and data collection. More than 550 people with diabetes and 30 health professionals 
completed the M-PRODIA study protocol and data collection was closed in April 
2021. 
In January 2021, the Danish Health Data Authority finalized a national pilot 
evaluation report about the PRO diabetes tool, building on 55 interviews with PWD, 
evaluation workshops with multi-disciplinary diabetes health professionals and 
preliminary M-PRODIA data by the author. The report concluded that the PRO 
diabetes tool was found to be feasible, acceptable, and helpful to improve the quality 
of dialogue and care visits 193. All seven diabetes sites involved in evaluating the PRO 
diabetes tool concluded that the PRO diabetes tool was value-adding. Several diabetes 
centers opted to continue use immediately after the pilot study was completed.  
 
On March 2 2021, the steering group under the Danish Ministry of Health approved 
the broad use of the PRO diabetes tool in routine diabetes care in Denmark.  
 
Led by the author of this thesis, a scientific study (study XIII) is ongoing to evaluate 
the impact and value of patient involvement in the Danish PRO diabetes tool program 
from 2017-2021. The field work concluded with two final patient evaluation 
workshops in April 2021. Participating PWD provided very positive evaluations of 
the process of involvement and the resulting intervention. The complete results are 
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being prepared for analysis using the Nvivo database that was established at the 
beginning of the development program.  
 
Figure 1. Illustration of phases and patient and multi-stakeholder involvement 
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I:  Core set of patient-important diabetes outcome constructs. 
II: Pilot study to evaluate clinical feasibility and acceptability. 
III: Design of the multi-center study M-PRODIA. 
IV: Narrative review about use of digital PRO in routine diabetes care. 
Paper V 
 
Results of a national Danish survey of 8,938 PWD:  
Psychometric validity of PRO diabetes items and clinical utility 194. 
Factor structure, internal consistency, discriminatory, construct 
validity, predictive validity. 
 
Paper VI Design and clinical user testing of the digital PRO diabetes tool. 
A clinical multi-disciplinary, multi-stakeholder development process to 
define functionality, design, and content of a digital PRO diabetes tool. 
Paper VI-
IX 
Results papers for the national multi-center study (M-PRODIA):  
VI: Primary outcomes for PWD. (n > 550 PWD using PRO, 7 sites). 
VII: Primary outcomes for HCP. (n >480 PRO visits, 31 HCPs) 
VIII: Public health impact potential for PRO diabetes (RE-AIM). 
Paper X-
XII 
Results of the hospital based clinical trend study (C-PRODIA): 
X: Baseline clinical, PRO and health care utilization baseline data.  
XI: Follow-up analysis of clinical and PRO tend data over 1-2 years. 
XII: Use of PRO diabetes data for value-based healthcare. 
Paper XIII Methodological description and evaluation of impact of systematic 
patient involvement and multi-stakeholder participation at each step of 
the development of the PRO diabetes tool. 
Paper 
XIV 
Psychometric analysis of PRO data from national pilot study: 
Psychometric characteristics, norms, scale structure, and scoring 195.  
Table 1. Overall publication plan and context for the 4 papers of this thesis. 
Papers V-XIV are in development. 
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2.2. 2017: INITIATION OF THE VALUE-BASED DIABETES CARE 
PROJECT AND SCOPING PHASE 
In fall 2017, the VBHC-PRO-DIA project was initiated by Region Northern Denmark 
under the auspices of the national value-based care program of the Danish Regions. 
The ambition of the project was to explore scalable models for implementation of 
principles of value-based health care 48 in Denmark. The aim was to create value for 
PWD in the healthcare system by aligning efforts across the care system towards 
measuring and improving a shared set of outcomes which matter to PWD 30.  
While several aspects of the value-based care framework was found to not be easily 
applicable to either diabetes or the Danish health system, the value-based ambition to 
“Improve outcomes by focusing care on what creates the most value for each person 
with diabetes” which was established in the early phase of the project was found to be 
an appealing and unifying goal for both PWD and other diabetes stakeholders in 
Denmark.   
The pre-defined goal of the first phase of the project was to establish consensus among 
a national multi-stakeholder working group on how to measure outcome (“value”) of 
diabetes care in a way that reflects the priorities of PWD. Multi-disciplinary 
representatives agreed that no core set of outcomes existed at the time. The rationale 
was that having a clear and shared picture of what success looks like across 
stakeholders could facilitate improved collaboration for better care and potentially 
help to break silos across health sectors and professions as it facilitated consideration 
of long-term opportunities for shared population health accountability 84,196.  
Study I describes how PWD were involved to strengthen the consideration of the 
perspective of PWD in the consensus process of the national working group for value-
based diabetes care appointed by the Danish Regions 1.  
As described in detail in study I, it was concluded that supplementing clinical outcome 
indicators with measurement of multiple PRO constructs 197 which reflect the 
priorities of PWD was a shared priority (Appendix I). 
2.3. 2018: DESIGN OF THE NATIONAL PRO DIABETES 
QUESTIONNAIRE 
In January 2018, the national PRO diabetes program was initiated under the auspices 
of the PRO Secretariat of the Danish Health Data Authority in collaboration with 
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VBHC-PRO-DIA with the goal to develop a national PRO diabetes questionnaire for 
use in the national PRO IT infrastructure 198,199.  
The key objective was to develop a digital PRO diabetes tool (comprised of a 
questionnaire, scoring algorithms, and instructions) for use in routine care to increase 
the influence of PWD on their own care, the quality of the PWD-HCP dialogue, and 
the quality, coordination, and efficiency of care provided.  
The program was initiated in close collaboration with the VBHC-PRO-DIA project in 
order to combine scientific and organizational resources and achieve one unified 
national PRO solution rather than having potentially overlapping  solutions for use in 
different health care settings.  
Figure 1 shows 5 workshops with PWD and 5 meetings of the national working group 
for PRO diabetes (KKG) which consisted of approximately 40 multi-disciplinary 
experts, diabetes advocates, and stakeholders representing all 5 regions in Denmark.  
Multi-stakeholder participation was facilitated within the general framework and 
governance model of the Danish Health Data Authority for participatory design of 
PRO tools as starting point 167,198.   
A stepwise approach to development of the PRO diabetes tool was used to structure 
planning of patient involvement activities for each stage (table 2). PWD and multi-
stakeholder perspectives were solicited for each step of the process through a 
combination of workshops, meetings, and surveys (figure 1). Patient workshops 
covered all stages, including aims, program theory, PRO constructs, questionnaire 
content, clinical and practice use, iterative testing, pilot testing and implementation. 
 Key steps for the development of the 
PRO diabetes tool 
Focus areas for patient 
involvement (examples) 
1 Aims, purpose, model. Program 
theory. 
Co-design of aims, measurable 
patient-centered outcome goals and 
model for use of PRO across the care 
system for PWD. 
2 Prioritization of PRO topics and 
constructs. Conceptual PRO model. 
Required PRO constructs and 
topics. Definitions, rationale and 
prioritization of each topic. 
3 Psychometric construction of 
questionnaire (items, scales, format, 
scoring, composition). 
Requirements and quality criteria 
for content and format of PRO. 
Iterative co-design of PRO content. 
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4 Design of decision-making support 
algorithms, model for clinical use. 
Acceptability, relevance and details 
of methods for use of PRO in visits 
5 Formative evaluation of feasibility, 
acceptability, utility, and efficacy 
Iterative testing, adjustment, and co-
design of complete digital PRO tool  
6 Pilot testing of feasibility, 
acceptability, value and public health 
potential. 
Systematic large-scale evaluation of 
PWD experience of use and benefits 
7 Adjustments, preparation and 
implementation planning. 
Final adjustments required based on 
systematic evaluation and validation 
8 Integration and quality assurance in 
standard care, ongoing improvement. 
Strategies for effective 
dissemination, implementation and 
ongoing quality assurance 
Table 2. Key steps for design of PROs for use in clinical practice with requirement 
for systematic involvement of patients.  
The design of activities for patient involvement was developed by the author with 
PWD and the Danish Diabetes Association using seven quality criteria for patient 
involvement 160,181 and relevant best practices for patient involvement as guidance 
4,200. The seven quality criteria are listed in table 3 with a brief explanation of how 
they were operationalized in the research plan for design of the PRO diabetes tool. 
 Quality criteria Application of criteria for PRO diabetes 
1 Aims and purpose Co-design and co-ownership of scope, priority 
and goalsetting for PRO tool. 
2 Respect and accessibility Discuss needs and actions required to ensure 
respect for patient’s roles and diversity of 
perspectives with participants early on. 
3 Representativeness of 
stakeholders 
Define how to ensure all the relevant 
perspectives of PWD are represented. 
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4 Roles and responsibilities Ensure roles, responsibilities, and tasks of 
PWD and other stakeholders are clear to all. 
5 Capacity and capability for 
engagement 
Ensure all patients are supported as needed to 
have capacity and capability to fully fulfill the 
intended role as partner in each activity. 
6 Transparency in 
communication 
Communicate process and results of patient 
involvement transparently and facilitate 
broader, public information and discourse. 
7 Continuity and 
sustainability 
Plan how patient involvement activities can be 
used to set stage for sustainable involvement. 
Table 3. The seven quality criteria used to facilitate patient involvement in the Danish 
PRO diabetes program. The seven criteria are adapted from Deane et al 181. 
 
The quality criteria were used to define tangible strategies for patient involvement and 
allow for structured evaluation. Examples of tangible uses of criteria 1, 3, and 5 are 
provided below. An example of use of criteria 1 (aims and purpose) was: PWD were 
involved in open dialogue about the aims and scope of the PRO diabetes program  
already in the scoping phase. This provided the PWD with concrete opportunities to 
influence the foundation of the program and facilitated a sense of shared ownership. 
Patient input specifically facilitated the national decision to pursue one unifying 
national PRO diabetes questionnaire rather than pursue multiple questionnaires for 
different purposes. Patient input also led to specification of additional potential 
benefits of PRO diabetes which were of interest to PWD and had not been previously 
identified. For example, PWD noted that it would be helpful if the PRO diabetes tool 
could help PWD navigate in the diabetes care system and better understand their 
options for acting to improve their health. Example of use of criteria 3 
(representativeness) included that input from PWD was used to guide the theoretical 
purposive sampling strategies for patient activities and studies II and III. This included 
defining the importance of representation of PWD with different types of 
complications, treatment regimens and care situations. Example of use of criteria 5 
(capacity and capability) included specification of what was needed for PWD to be 
able to fully participate in each patient involvement activity. The requirements were 
defined based on the research goals of the activity and were used to identify which 
support strategies were suitable to ensure each PWD had the capacity and capability 
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to be fully involved. These strategies included the use of telephone conversations with 
patients prior to meetings to assess individual needs, provision of pre-reading 
materials in lay language, use of reflective questions prior to meetings to prepare 
patients, and instrumental support for making presentations at meetings (e.g. pictorial 
representation of patient insights on posters or presentation design). 
Each of the patient workshops shown in figure 1 was planned around detailed patient 
involvement aims specific to each PRO development stage and key decision points of 
the next multi-stakeholder working meeting.  
Registration and coding of data in NVivo was done to enable systematic use of patient 
insights on an ongoing basis to strengthen patient insights management, improve the 
formative evaluation process, and enable subsequent evaluation of the effectiveness 
of patient involvement 201. Initial results of impact of patient involvement in first 
phases were presented by the author in 2019 160.  
Patient involvement in the planning of patient involvement in the scoping process led 
to important actions to ensure effective use of patient perspectives by the multi-
stakeholder working group in accordance with the seven quality criteria; A stand-
alone patient workshop was conducted prior to each national multi-stakeholder 
working meeting which generated robust patient insights relevant to the specific 
research and design questions that focused on the particular national working meeting. 
The patient workshops ensured that the relevant topics had been comprehensively 
discussed in a representative patient group in advance of each multi-stakeholder 
meeting. To ensure effective co-learning and consideration of the patient insights by 
the HCP stakeholders, the agenda of each multi-stakeholder working meeting started 
with a presentation by PWD of results of the outcomes of the preceding PWD 
workshop. Collaboration meetings were held with individual patient collaborators and 
the research team in advance of each multi-stakeholder meeting to ensure capacity 
and capability of the PWD for conveying the messages.  
The central placement of robust presentations by PWD on the multi-stakeholder 
workshop agendas facilitated understanding, awareness, co-learning and respect 
regarding the relevance of patient perspectives among all stakeholders at each stage. 
Patient involvement activities were developed for each of the eight steps of the PRO 
design tool in table 2 taking into account the general quality criteria listed in table 3. 
For each development stage, project responsiveness to patient insights was registered 
by assessing concrete impacts of patient inputs on the program’s design decisions. 
As example, at step 2 (table 2) of prioritizing topics for inclusion in the PRO tool, a 
combination of home reflection assignments, group discussions, and voting led to 
saturation for the patient insight that a wide range of diabetes topics were relevant and 
value-adding to measure by use of PRO also beyond mental health, diabetes distress 
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and individual self-care goals. The verification of PWD’s preference for evaluating a 
broad range of PRO constructs to evaluate outcomes (study I) was important because 
the prevailing recommendations for clinical practice focused on the use of PRO to 
mainly monitor mental health problems 27,86. Without the systematic planning of 
patient workshops to examine this specific aspect early in the process, the PRO 
diabetes project could likely have ended up focusing only on psychological issues. 
2.3.1. MULTI-STAKEHOLDER PARTICIPATION TO AUGMENT PATIENT 
INVOLVEMENT 
Effective systematic patient involvement depends on effective integration of patient 
stakeholder involvement in the multi-stakeholder decision-making process 167,170,171 
and multi-stakeholder co-ownership of patient-centered health objectives. A patient-
orientated multi-stakeholder participation process 5,202  was therefore designed in the 
PRO diabetes program to ensure a research development environment which 
facilitated 1) iterative, contextual, mutual learning182, 2) a collaborative environment 
with balanced decision power across stakeholders176, and 3) a project governance that 
allowed for responsiveness of the overall project to insights resulting from 
involvement. Table 4 lists key strategies for multi-stakeholder participation used in 
the Danish PRO diabetes development program which synergizes with and serves to 
augment patient involvement activities 168,171.  
1. Shared clear picture of national scope and mandate for all stakeholders 
2. A clear patient-centered and measurable objective (e.g. improved the experienced quality 
of the PWD-HCP dialogue and diabetes care visit). 
3. Clear, well-defined governance model from the outset. 
4. A commitment to and plan for democratic involvement of all parties to achieve shared 
ownership: tailored approaches to equal involvement of each stakeholder group based on 
individual stakeholder needs and opportunities.  
5. Planning of special activities and approaches to facilitate the understanding among all 
stakeholders of the perspective of PWD and FM using a humanistic and holistic approach to 
insights generation, management and dissemination. 
6. Definition and articulation of purpose, objectives, and evaluation goals from the outset. 
7. Definition of terminology and relevant concepts or conceptual framework. 
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8. Transparent communication and clarity regarding roles of all stakeholders. 
9. Early, ongoing focus on identifying requirements for sustainable implementation 
including barriers, facilitators and critical organizational, political and resource issues. 
10. Willingness to respond to and consider ongoing and iterative input and feedback to 
ensure an optimal end-result. 
11. Open, respectful communication and collaboration across disciplines and sectors. 
12. Project responsiveness and flexibility to react to empirical findings indicating 
requirements for adjustment of assumptions or pre-planned methods underway. 
13. Systematic approach to evaluation, rooted in originally agreed goals and objectives, 
involves all parties, and with goals aimed also at long-term impact. 
14.  Intention and plans to secure continuity of established relations and collaborative 
capacity and support of ongoing quality and development over time. 
Table 4. Strategies for multi-stakeholder participation used to augment patient 
involvement in the Danish PRO diabetes program. Adapted from Skovlund et al199. 
2.3.2. PROGRAM THEORY FOR THE PRO DIABETES TOOL 
In step 1 of the process listed in table 2 in 2018 overall aims, methods and desired 
outcomes for use of PRO in diabetes were clarified using patient involvement and 
multi-stakeholder working meetings. Key elements of the program theory, defining 1) 
how the intervention is intended to work and for whom and 2) what the intended 
outcomes were and possible mechanisms of actions 203 are summarized in table 5. The 
hypothesized mechanisms of action of the PRO diabetes tool were refined by 
stakeholders during the design process and provide initial guidance for hypothesis 
testing in line with relevant clinical, behavioral, and psychological diabetes theoretical 
and methodological frameworks 4,152,204,205.  
A. Target 
group 
All adults (over 18 years) diagnosed with either type 1 or 2 diabetes. 
PRO tool to be used across the adult life span. 
B. 
Setting 
Secondary Care: Annual nurse visits, initial medical examination. 
Municipality: Initial, ongoing and evaluating diabetes visits. 
Primary Care: Extended primary care diabetes visits.  
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Secondary care: Diabetes nurses, physicians and dietitians. 
Primary care: Physicians, nurses and relevant other staff. 
Municipality: Nurses, physiotherapists, dietitians, social workers.  
D. PRO 
model 
PWD completes PRO questionnaire 1-10 days prior to visit.  
HCP and PWD use PRO data as dialogue tool to plan care together. 
E. Key aims and mechanisms of action: 
Aim: Improve diabetes care by increasing active patient participation and 
improving quality of patient-HCP dialogue. 
Specific aims: 
-Increase active participation of and influence of PWD on their care. 
-Improve quality of the PWD-HCP dialogue and the care visits. 
-Increase comprehensive review and attention to biopsychosocial needs 
-Improve priority setting in care based on what matters most to each PWD. 
-Improve quality of care and coordination 
 
Secondary uses and intended benefits of the PRO diabetes tool include: 
Visitation support: Tailor care plans according to individual needs to ensure more 
effective use of care resources and minimize waste. 
Decision support: Use individual PRO scores to support decisions about treatment. 
Analytical use of PRO-data: Use PRO data to improve quality of care and services 
locally and nationally, for value-based diabetes care and person-centered research. 
Table 5. Program theory for the Danish PRO diabetes tool. This program theory was 
synthesized by the author based on multiple data sources 3.  
While it is not in scope of this thesis to present the detailed patient involvement 
methods and techniques applied in each of the steps of development, this section 
exemplifies process elements pertaining to systematic patient involvement in step 2 
(prioritization of PRO topics) and 3 (questionnaire construction). 
2.3.3. PATIENT INVOLVEMENT IN SELECTION OF PRO CONSTRUCTS 
The constructs to be included and the hypothesized rationale for the use of each 
specific construct in routine care were co-designed through an iterative process 
involving patient workshops and focus groups which mapped topics of relevance 
across the patient journey in the healthcare system. The process included divergent 
and convergent phases. PWD and HCPs completed individual surveys prior to 
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meetings, the national working group achieved consensus on a final list through 
workshops and a plenary consensus process. Systematic literature reviews and 
relevant methodological frameworks guided and qualified the process.  
Patient involvement activities focused on 1) Defining each construct and the rationale 
for its inclusion from the patient’s perspective 2) Identifying where to use the outcome 
in the patient care journey and potential limitations to use, 3) Describing the latent 
construct in the language of PWD. 4) The author examined relevant theoretical and 
empirical research pertaining to potential known patient benefit, clinical utility, 
psychometric measurability and theoretical foundation. The topics and constructs 
agreed for inclusion in the Danish PRO diabetes questionnaire by the multi-
stakeholder group are shown in table 6. Examples of research supporting the clinical 
relevance and measurability of each construct are cited. 
1. General health 206,207 
2. Psychological well-being 7,143,149,208 
3. Depression 209 
4. Social Support 210,211 
5. Life issues affecting diabetes 42,59,135,142,212–215 
6. Diabetes in daily life 57,141,216 
7. Diabetes-related distress 18,19,137,217–222 
8. Limitations due to diabetes 19,223, 
9. Diabetes Social Support 7,11,28,134,141,223–226, 
10) Confidence in diabetes self-management related to global confidence, eating 
healthily, physical activity, weight, blood glucose monitoring, reacting to high and 
low blood sugars, insulin injection and dosing, diabetes knowledge, use of diabetes 
technology 67,69,227–236. 
12) Symptom distress screening 237,238; 13) Monitoring somatic symptom distress 
related to: Neuropathic pain 239–241, 14) Gastrointestinal 19,242–246, 15) 
Cardiovascular 238, 16) Sexual dysfunction 19,247–250, 17) Sleep 130,251–256, 18) 
Cognition, fatigue, tiredness 238,257–259 (excluded after pilot test) 19) Foot ulcer 260–
262. 
20) Annual checkup: Eyes and feet 7 
21) Confidence in access to HCP 263, 
22) Medicine experience, challenges and satisfaction 16,19,134,243,264–272 
23) Blood sugar regulation and hypoglycemia 6,7,12,18–21,212,237,243,273–279 
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24) Hypoglycemia unawareness 278,280–283 
25) Hypoglycemic event requiring assistance 21,284–286 
Wishes for Support 57 (excluded after pilot test) 
Desired topic to discuss at next visit 142. 
Table 6. Overview of main constructs and topic categories for the PRO diabetes 
questionnaire. 
Topics or constructs not qualifying as traditional “health outcomes 84 were included 
as “other health constructs” 5,50,104,133,287 or Patient Reported Input (PRI) 4 if considered 
essential for the PRO tool to serve its purpose by PWD and HCP. Relevant theoretical 
foundations and empirical evidence were considered as guidance for each topic from 
diabetes psychology 27,288, social cognition theory 289,290, health and illness beliefs 
model 291,292, self-determination theory 293,294, empowerment 45,68,69, behavior change 
theories 152, diabetes self-management education 35,290,295. The process prioritized 
PWD’s and HCP’s experience-based perspectives but ensured consideration of 
psychometric evidence whenever relevant. As an example of the balanced approach, 
diabetes self-management had been identified as a priority topic to include, and 
stakeholders initially had different perspectives on what this construct entailed. Some 
HCP found it important to measure self-reported alcohol intake, smoking, unhealthy 
diet and sedentary lifestyle as it reflected on their care responsibility. PWD found the 
experience of confidence in managing diabetes more helpful (study I) and preferred 
questions about confidence compared to existing standard questions about alcohol 
consumption, smoking and unhealthy eating. PWD expressed that all questions in the 
PRO questionnaire should project trust and respect and should avoid a paternalistic 
approach. It was noted that even if it was just a few items that were perceived as 
insensitive or irrelevant by the PWD it could be counterproductive and demotivate the 
PWD. Assessment of confidence in diabetes management has been shown to function 
well as an intermediate outcome goal for diabetes self-management education 
204,216,289,296,297. While some self-assessment scales for health behavior and medicine 
taking correlate with objective indicators 298,299 it is difficult to obtain reliable 
measures of health behavior using short self-assessments as would be required for the 
PRO diabetes tool. The multi-stakeholder group agreed to include questions about 
confidence with self-management. Care centers requiring the use of detailed health 
behavior questions would then administer potential behavioral self-assessment items 
separate to the PRO diabetes tool. 
Linked to self-management, PWD and HCP agreed to incorporate a broad global 
question about barriers to diabetes management covering general life issues, including 
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comorbidity, work,  financial situation and other to complement the confidence 
assessment. Including such a construct is supported by clinical models for integration 
of social determinants of health 300, behavior change theory  152,  and self-efficacy 
theory in diabetes care 42 which recognize the importance of psychosocial resources, 
beliefs, attitudes, and external barriers for diabetes management. Similar approaches 
were taken for all other constructs with use of empirical evidence to substantiate the 
decisions made by HCP and PWD and build on the patient-important outcomes 
identified in study I.  
 
2.3.4. PATIENT INVOLVEMENT IN BUILDING THE QUESTIONNAIRE 
Based on a literature review and desk research involving all the stakeholders in the 
development process, it was concluded early on that no previously psychometrically 
validated diabetes PROMs existed which covered all of the PRO topics selected for 
inclusion in the Danish PRO tool and fulfilled the additional requirements for clinical 
utility and person-centered language.  
A protocolized stepwise procedure for patient involvement in selecting PRO items 
and scales for the development of a questionnaire battery was therefore undertaken as 
part of step 3 (table 2). For each construct 128,195, insights from PWD were combined 
with HCP practice experience, and psychometric methodology and literature review.  
Requirements for items were defined based on workshops and meetings with PWD, 
the program theory, and literature review of patient-orientated PRO research 154,301. 
The specific PWD preferences for items are listed in table 7. These criteria were 
applied as a supplemental to the requirement of psychometric validity and reliability 
of items in accordance with the intended use of each item or scale 4.   
Items for use in the PRO diabetes questionnaire should 
1) Be simple, easy and unambiguous to understand for all PWD in the target group.  
2) Be unbiased, non-judgmental, non-paternalistic. Adoption of principles for 
person-centered non-stigmatizing diabetes language5,54,302. 
3) Balance positive and negative wordings and avoid one-sided problem focus. 
4) Be evidently relevant for the PWD in the context it is used.  
5) Yield easy-to-interpret outputs which PWD and HCP can understand and act 
upon. 
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5) Support active participation of PWD in own diabetes care. 
6) Have the potential to lead to improvement in patient-important outcomes. 
Table 7. Patient-based criteria for selection and development of items for use in the 
PRO diabetes questionnaire. Adapted from Skovlund et al 4 
Patient preferences regarding the questionnaire as a whole included not being too 
large, clear brief instructions, consistency in the way questions are asked, logical, 
intuitive order of topics and items, and the possibility to complete it on mobile, tablet 
or PC. The item criteria in table 7 defined by PWD had implications for the final 
design of the Danish PRO diabetes questionnaire. The multi-stakeholder working 
group placed greater weight on factors related to person-centered diabetes language 
than on including pre-existing scales with proven validity in line with growing 
recognition that non-person-centered diabetes language may contribute to diabetes 
related distress 5,54,302. During the detailed review of candidate scales and items by 
PWD and the working group, internationally validated scales such as SF-12 303, PHQ-
9 304, PROMIS-10 130, EQ-5D 305, Diabetes Distress (DDS) 306,307, Problem Areas in 
Diabetes (PAID) 224, and Summary of Diabetes Self-Care Activities Assessment 
(SDSCA) 236 were not included based on one or more of the patient-based 
requirements.  
Using the agreed patient-centered criteria, the following key steps were undertaken to 
select or design items for all of the constructs identified to be included:  
1) Identifying and evaluating existing previously psychometrically validated PRO 
items or tools based on literature analysis and desk research 92. Using existing items 
if they fit the construct and meeting agreed pre-defined criteria relating to 
acceptability, relevance, validity, and utility. 
2) If no existing items/tools were available, evaluating basis for adaptation of parts of 
pre-existing tools or modification as feasible utilizing own and literature-based 
qualitative research as guidance. 
3) If no existing items/tools were available or suitable for use or adaptation, co-
developing new items based on the perspective of PWD as ascertained from working 
meetings, workshops, interviews and literature reviews through a collaborative 
process involving PWD and HCP. Verbatim notetaking was used in workshops with 
PWD to facilitate use of language reflective of the everyday lived experience. 
To meet the preferences of PWD and achieve the required multi-dimensional topic 
coverage while maximizing brevity, techniques of branching logic, global rating 
items, and brief multi-item scales were used.  As the primary purpose of this PRO tool 
was dialogue support and there was an interest from the project to potentially use 
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shorter versions in primary care or with vulnerable patients, global rating scales 
drawing on the method of “global essence domain items” 218 were used to co-design 
global items for select constructs. The method differs from scale reduction by 
selecting the item explaining the greatest amount of the variance 137,139 as this method 
may result in too narrow of a construct.  
When new items were required, PWD were involved in early generation of global 
items to incorporate lay wording and capture the essence of the latent constructs. 
Response options were iteratively adjusted in order to cover a wide range matching 
the estimated variance in the population. The aim was to include a hypothesized 
hierarchical structure which would require psychometric validation pending 
quantitative data collection. All adapted or newly designed items were always 
evaluated by the entire national multi-disciplinary working group to optimize their 
face validity, clinical utility, and appropriateness from the perspective of all the 
stakeholder and care setting perspectives. Adjustments were proposed in a co-design 
process and consensus on a final version was established which also took into account 
relevant psychometric format and design considerations 92,102,104,128. The latter 
involved soliciting qualitative insights and input important for face validity, 
acceptability, appropriateness, comprehension, comprehensiveness, content validity, 
perceived relevance, reliability, responsiveness, interpretability and utility, both from 
the perspective of PWD and HCP and related to the theoretical or empirical basis for 
the specific measurement impacting care quality and patient outcomes. 
5-point Likert scales with verbal anchors and use of simple transparent scoring were 
generally preferred by PWD which was in line with psychometric evidence supporting 
acceptability, low cognitive burden, and user-friendly interpretability.  
The final PRO diabetes questionnaire was reviewed and optimized in its entirety in 
patient involvement research workshops with PWD who were recruited using 
purposive sampling in fall 2018. The psychometric literature review and design 
process for the PRO diabetes questionnaire is not the focus of this thesis but examples 
of the use of related patient-centered psychometric to qualify the co-design process 
are provided in the following section. The main previously psychometrically 
evaluated questionnaires incorporated into the PRO diabetes questionnaire were the 
global health item from SF-1/PROMIS 130,206,207,308, the WHO-5 Well-Being Index 143, 
the MDI-2, a short form of MDI-2 209, a 2-item loneliness scale from the national 
Danish Health Profile 211, the Diabetes Symptom Check List (DSC-R) 238,309, the 
PROMIS sleep quality item 254, Karolinska Sleep Scale Short Form 255,256, and the 
Hilleroed Screening Item for Hypoglycemia Unawareness 280,310. The review and co-
design process for PWD and HCP was guided by ongoing user testing, qualitative 
research and consideration of related psychometric research already done for the 
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identified constructs. Confidence in diabetes self-management was measured using a 
Danish adaptation of the Confidence in Diabetes Management Questionnaire 311 
which uses simple questions asking about confidence in ability to manage different  
aspects of diabetes. User testing and workshops resulted in iterative re-wording of 
items to achieve the desired person-centered language. The measurement construct 
was supported by previous research related to the Perceived Competency For Diabetes 
Scale (PCD)205 (Diabetes Self-efficacy Scale (DES)216 Diabetes Self-Management 
Questionnaire (DSMQ)235, the Perceived Diabetes Self-management Scale 
(PDSMS)297. Diabetes stress was for example assessed with consideration of research 
pertaining to PAID-1 137, PAID and DDS 22,306, limitations due to diabetes was 
assessed with consideration of empirical diabetes research related to QDIS 217–219 and 
SF-12 303, gastrointestinal symptom distress was assessed using the generic 
questionnaire format of the DSC-R 309 and with consideration of previous empirical 
psychometric research 19,246,312. Similarly distress related to sexual dysfunction was 
assessed with iterative item adaptation to accommodate PWD’s preferences and 
consideration of related psychometric research 19,247. Satisfaction with medical 
therapy was assessed taking into account the broader patient-centered psychometric 
research field of treatment satisfaction and experience, focusing on the core 
components of perceived efficacy, side effects, convenience and ability to take the 
medicine as prescribed or desired 19,133,270,313.  Specific research questionnaires 
considered included ITSQ 16, GDTS 134, DiabMedsat 19,243, Treatment Satisfaction 
Questionnaire for Medication (TSQM) 270. A multi-faceted model for understanding 
barriers to “treatment adherence” was considered in the co-design of a global item 
regarding medication taking 266,314. The co-design of items to measure perceptions of 
blood sugar regulation and burden of hypoglycemia was guided by extensive 
empirical psychometric research related to perceptions of hypoglycemia, blood sugar 
fluctuations and perceptions of blood sugar regulation in general.  Treatment-Related 
Impact Measure for Hypoglycemia (TRIM-HYPO)277, DiabMedSat 19,243, Diabetes 
Care Profile (DCP) 286, DAWN2 12, and the Fear of Hypoglycemia Survey (FHS) 315.  
 
The content of the Danish PRO diabetes questionnaire which was tested in this thesis 
is presented in table A13 of appendix III. A final version of the Danish PRO diabetes 
questionnaire was approved by the Danish Health Data Authority in March 2021. A 
complete copy of the entire final PRO diabetes questionnaire is available to 
the reviewers of this thesis from the Department of Clinical Medicine, Aalborg 
University upon request. Information to PWD and a video about how the PRO 
diabetes questionnaire is used in practice is available at http:\www.diaprofil.dk. 
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2.4. 2019: ITERATIVE TESTING AND FORMATIVE EVALUATION 
OF THE DIGITAL PRO TOOL  
In 2019, iterative user testing of the nationally agreed diabetes questionnaire was 
undertaken and PWD were interviewed using cognitive debriefing methods 316 to 
examine comprehension and the potential for measurement error.  
A subset of items were included in a national diabetes survey study with the Diabetes 
Association using population survey research methods 8,317 to examine the 
psychometric performance of newly designed items in a population health setting 318. 
Factor and correlational analyses showed that 3 items co-developed by PWD, as 
hypothesized, measured perceived negative impact of diabetes. The multi-item scale 
score had satisfactory internal consistency reliability (Cronbach α=0.78). 
Hypothesized, perceived negative impact of diabetes was associated with use of 
intensive insulin therapy, greater burden of late stage complications and a greater 
expressed interest in obtaining a referral to a psychologist (p<0.05, One-way Anova) 
318. A psychometric analysis of the entire questionnaire will be undertaken in April-
July 2021 and published as paper XIV.  
In 2019, the digital PRO dialogue support tool, DiaProfil, was finalized for clinical 
testing. The goal was to establish a digital health tool that would allow for a user-
friendly completion of the PRO diabetes questionnaire by PWD at home via phone, 
tablet, or the internet and be suitable for seamless active use by HCPs during visits 
with PWD.  
The functionality was co-designed with PWD and a multi-disciplinary clinical 
diabetes care team drawing on empirical insights from the author’s previous digital 
PRO projects with teenagers 135,319 and adults 62,142 with diabetes using user-centered 
methods 150,151. Previous research indicated that PRO tools may not necessarily change 
HCP care practices beyond dialogue quality 155,156. As changes in care practice was 
considered essential for optimizing potential impacts of the PRO diabetes tool on 
health outcomes, and it had been agreed with PWD that questions should only be 
included in the PRO tool if HCP were able to act on the results, the digital PRO tool 
was designed with a new functionality, action support, to make it easier for HCPs to 
follow-up on every potential PRO output.  
This involved that the author and the clinical diabetes care team at Aalborg University 
Hospital mapped dialogue tools, self-help resources, treatment and referral options, 
and community-based support resources for every PRO construct and individual PRO 
output through systematic outreach to the extended cross-sector network of diabetes 
care, education and support services inside and outside of the hospital. This data was 
built into the digital PRO dashboard for the HCP to access with one click for each 
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PRO output during the visit. A flexible database structure was created to allow each 
diabetes center and clinic to establish their own locally tailored action support 
database for use in care visits.  
Team meetings provided a trusting, safe forum to facilitate formal and informal 
solicitation of views and perspectives as well as mutual learning by all members of 
the multi-disciplinary development during the digital tool design.  
The action support feature was favorably rated by users and hypothesized to 
potentially help increase concrete HCP follow-up action on each flagged PRO topic 
in accordance with evidence-based integrated chronic illness care 320. Specifically, it 
was intended to facilitate improved use of self-help resources, treatments and 
technology as well as both internal and external education and support resources. 
The action support function was also inspired from patient workshops regarding aims 
of PRO where PWD noted they hoped the PRO tool could help PWD understand and 
navigate their options for acting to improve their health. Another key feature created 
in response to user input was the establishment of a “single-screen overview 
dashboard” which gives an at-a-glance overview of the PRO results of PWD. This 
was based on HCP input that to facilitate high adoption, as defined in the RE-AIM 
model for optimization of public health impact of the intervention, it was important 
the PRO tool was easy and quick to use in between visits in daily practice. An at-a-
glance overview screen was achieved by clustering PRO results into 9 main themes 
which corresponded to key outcome constructs identified in study I. A third new 
feature, a screen suitable for shared equal use by PWD and HCP, was developed based 
on wishes of both PWD and HCP to be able to discuss results in a reciprocal way 
using person-centered communication 7,321,322. This deviated from the existing HCP-
orientated standards for PRO dashboards which showed PRO data inside clinical HCP 
interfaces. A traffic-light coloring scheme determined by a scoring algorithm for all 
PRO responses co-designed by the multi-stakeholder working group with PWD input 
was used to present the PRO results on the screen. Green indicated no problems, 
yellow indicated potential issues to discuss, and red indicated potential issues which 
should be addressed. The design of the colors was iteratively adjusted based on input 
from PWD to ensure optimal acceptability. For example, initial tones and sizes of red 
and yellow colors to make the screen appealing and minimize inadvertent signaling 
of danger or concern. The resulting dashboard was appealing to both HCP and PWD. 
PWD found it intuitive to read and confirmed it provided a good representation of 
their current diabetes situation. A screen shot of the PRO dashboard is depicted in 
study II and III (appendix). Study II evaluated the experience of use of DiaProfil in 
routine visits and collected data to guide the design of the longitudinal clinical study 
at Aalborg University Hospital (C-PRODIA) and the multi-center study, M-PRODIA.  
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Study III describes the M-PRODIA study protocol which involved two hospitals, four 
municipality diabetes centers and one primary care practice (study III).   
2.5. 2020: NATIONAL MULTI-CENTER PILOT STUDY 
During 2020, the national PRO diabetes questionnaire tool was pilot tested under the 
auspices of the National Health Data Authority in collaboration with VBHC-PRO-
DIA. As part of this project, data was collected from more than 550 PWD and 30 HCP 
for mixed method evaluation of questionnaire reliability, validity, acceptability, and 
examination of perceived benefits as well as implementation barriers and facilitators 
(appendix III). Half-way into the study in mid-2020, statistical and psychometric 
analyses were done on preliminary data from the M-PRODIA study to examine 
distributions, scaling and response option issues,  scoring algorithms, cut-of scores 
and potential interpretability issues  together with the clinical teams. In some cases, 
scoring algorithms for color coding of questionnaire responses were adjusted due to 
ceiling and floor effects and to fit clinical experience. Initial psychometric testing, 
including factor analyses, correlation analyses and known-group validity testing was 
done to confirm the quality of the data. 
2.6. 2021: NATIONAL EVALUATION AND APPROVAL OF THE 
DANISH PRO DIABETES TOOL 
In December and January 2021, preliminary data from quantitative PRO data and PRO 
evaluation questionnaire data and interview data from the M-PRODIA study were 
consolidated by the author in order to support the final evaluation of the PRO diabetes 
tool pilot by the Danish Health Data Authority.  
On January 19, 2021, the national clinical coordination group for PRO diabetes 
convened again for their fifth national meeting to review the completed national 
evaluation report, review the results of the pilot test at each of the participating sites, 
decide on final adjustments to the PRO tool based on the pilot data, and make final 
recommendations regarding implementation. 
Each of the participating sites reported that they found the PRO diabetes tool fit for 
purpose and considered it acceptable, usable and value-adding as a dialogue support 
tool to augment their care for PWD. The tool was found useful both for people with 
type 1 and type 2 diabetes and in both hospitals and municipalities. Benefits that were 
reported were closely aligned with the pre-defined program theory.  
The national working group agreed on minor adjustments to the questionnaire and 
scoring algorithms based on quantitative data analysis and qualitative analysis of 
evaluation inputs from PWD and HCPs during the pilot test. The final PRO diabetes 
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questionnaire was recommended for expanded use in outpatient diabetes clinics and 
municipality rehabilitation services for PWD. Due to the practical challenges and 
implications related to Covid-19, insufficient experience had been accumulated to 
make generalizable conclusions regarding utility of the PRO diabetes tool in primary 
practice so testing is anticipated to continue in primary practice in 2021.  
Psychometric and qualitative analyses are now ongoing by the author drawing on 
systematically collected research data from PWD involved in the program from 2017-
2021 in line with the publication plan shown in table 1. 
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CHAPTER 3. REVIEW OF STUDIES 
3.1 RATIONALE AND AIMS  
3.1.1. STUDY I:  
The aim of this study was to facilitate agreement on a national core set of diabetes 
outcome constructs for use to evaluate outcomes of diabetes care that appropriately 
reflects what matters to both PWD and HCP 1. Establishing consensus on how to 
measure value was defined as a critical starting point for the development of a possible 
future framework for use of value based diabetes care in Denmark 48.  
By identifying these outcome constructs, it would subsequently be possible to develop 
the operational methods to measure these on an ongoing basis as part of clinical care.  
When this study started, no existing consensus set had been developed that allowed 
for the evaluation of outcomes of care as well as quality improvement and value-based 
care in a way that aligns with the perspectives of both PWD and of HCP.  
While ample research has been undertaken regarding the general aspects of the lived 
experience with diabetes 29,110,146, this study aimed to systematically involve PWD and 
FM in Denmark as collaborators in exploring not only what issues affected them, but 
also what relevant outcome constructs to prioritize that would have potential for 
improving care. This required the design of specific involvement activities tailored 
for this purpose.  
3.1.2. STUDY II 
In early 2019, a new first of its kind Danish PRO diabetes questionnaire and clinical 
PRO tool was finalized. Content and functionality were new, and the tool had not been 
evaluated in Denmark previously. A formative pilot feasibility study was required to 
examine basic appropriateness,  acceptability, feasibility, fidelity and collect 
preliminary insights about perceptions of the tool in routine care 170. Specifically, the 
theorized benefit of the PRO questionnaire on PWDs’ level of active participation and 
perceived dialogue quality was applied as hypotheses to be preliminarily evaluated 
using mixed-methods research. We used qualitative insights from workshops, focus 
groups and clinical user testing of early digital prototypes to design the study 
materials. PWD gave input to the study aims, study design and wording as well as  
Likert-scale evaluation questions.  
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3.1.3. STUDY III: 
As part of the Danish Health Data Authority’s procedure for development of national 
PRO questionnaires, a qualitative pilot test was planned to evaluate the practical 
experiences with use of the PRO diabetes questionnaire and its potential for 
implementation. The initial scope was not to undertake a scientific evaluation. In line 
with the aim to apply systematic patient involvement in all phases of the PRO diabetes 
questionnaire program, Study III was designed to complement the national pilot test 
through systematic collection of subjective experiences from PWD and HCP and 
participating centers. These data would allow for scientific analyses of acceptability 
and development and initial testing of hypotheses in line with the program theory. 
This study was the first evaluation of the acceptability, perceived value, 
implementation and public health potential of a national PRO diabetes tool in 
Denmark.  
We did not identify previously psychometrically validated PRO evaluation 
questionnaires suitable for completion in busy routine care settings by PWD and HCP 
which would address the research questions identified as important by PWD and the 
national PRO diabetes working group. The rationale for the study was to obtain 
detailed quantitative insights into how PWD experienced the process of completing 
the questionnaire and use of their PRO data during their visit, and how they perceived 
the use of PRO affected their role in care, their diabetes care and their self-
management. The study aimed to establish a pragmatic research data collection  
protocol that would piggy back on the planned practical pilot testing to generate 
unique insights about acceptability and perceived value of the PRO diabetes tool in a 
large and diverse sample of people with type 1 and type 2 diabetes treated for diabetes 
across three different health care settings 3. An additional aim of the study was to 
develop and psychometrically evaluate Likert-based PRO evaluation questionnaires 
to be used also in the future for comparative evaluation of PWD and HCP’s 
experiences of PRO tools in different settings 3. 
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3.2. METHODS 
3.2.1. STUDY I 
The study design was aligned with general steps for design of core outcome sets 87 
and principles for patient involvement in research 181 and methods for qualitative 
analysis to augment the process 323. The study was designed in two main parts: 1) A 
structured set of patient involvement activities supported by qualitative analysis 
pertaining to the perspective of PWD in Denmark on selection of core outcomes and 
2) A stepwise consensus facilitation process for a multi-stakeholder expert group to 
prioritize and define a core set of clinical and PRO outcome constructs.  
The choice of method was driven by the primary aim to solicit insights about the 
specific perspectives of PWD regarding what outcome constructs should be included 
in a future solution to integrate outcomes evaluation in their routine care. The health 
outcomes hierarchy model of the value based health care (VBHC) model provided the 
methodological framework 196.  
Through input from a panel of PWD, a purposive theory-based sampling approach 
was defined 324 to optimize representation of factors identified as theoretically relevant 
including type of diabetes, diabetes duration, gender, therapy, age, and disease burden 
1. A group of 21 PWD and 5 FM were recruited in accordance with the pre-defined 
criteria.  
Detailed advance planning of patient involvement activities using multiple methods 
for engaging PWD as either advisors and collaborators as relevant for each research 
question and phase was undertaken 181. A combination of individual surveys, focus 
groups, workshops and plenary discussions were designed to match each research 
question to the most suitable research method as deemed feasible within the time and 
resource constraints of this phase of the value-based diabetes project. 
The data generated from this work was consolidated using a pragmatic approach to 
combining different involvement methods to achieve the optimal research outcome  
166,325. Workshop design and qualitative analysis was designed to achieve saturation 
as it was an important aim to identify a core set of outcomes which could be 
considered comprehensive by the representative group of PWD 162.  
A proposed candidate list, which reflected the priorities of PWD, was qualified using 
literature review and was used as a starting point for the work of a national value-
based diabetes care expert panel with the mandate to select a final core set of patient-
important outcome domains for use for value-based diabetes care in Denmark 1. The 
process for consensus was facilitated by using a candidate outcome list which 
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reflected both patient and clinician ratings of importance and using pre-defined 
criteria for the selection and prioritization of outcome domains.  
3.2.2. STUDY II 
A single arm feasibility and acceptability pilot study design was applied as the primary 
purpose of the study was to establish basic feasibility, acceptability, and perceived 
utility of the first functional version of the digital tool, DiaProfil, which at the time 
had not yet been tried in routine care visits. The underlying hypotheses, as defined in 
the PRO diabetes program theory, pertained mainly to the impact of the use of PRO 
on patient engagement and quality of the dialogue as well as to underlying 
assumptions about the mechanism of action developed during the participatory design 
that would be preliminarily evaluated using descriptive and qualitative analyses. The 
design was further guided by the aim to use the study for formative evaluation as part 
of iterative testing and refinement of the PRO questionnaire and digital tool. Since 
this was the first test of the Danish PRO tool in a routine setting the author included 
an exploratory component to prompt for any unintended or unexpected challenges, 
impacts and adverse events. 
Theoretical purposive sampling 324 was defined with input from PWD who helped 
define which attributes were most important to have representation of to adequately 
reflect the breadth of experiences related to acceptability and value of PRO. We 
recruited PWD attending regular scheduled diabetes visits at the outpatient diabetes 
clinic of Aalborg University Hospital.   
A pragmatic planned mixed-method design was used because it was deemed of 
significant value to triangulate data and thereby potentially strengthen the credibility 
of findings. Mixed-methods was chosen as method because it was believed that 
combination of the different data sources would strengthen the credibility of the 
findings especially considering the small sample size 164,326.  
The research questions were based on the initial program theory (table 5),  
hypothesized benefits of the PRO tool, input from PWD and guided by qualitative 
data from ongoing user testing. The benefits related to improved patient participation 
may be analyzed in context of several theoretical frameworks and models, including 
patient activation 327,328, empowerment 45,58, self-determination 205 and social cognition 
theory 289. 
All evaluation tools and final qualitative analyses and synthesis were developed by 
the author with input from the PWD, multi-disciplinary clinical care team and medical 
students involved in coding consultation transcripts.  
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3.2.3. STUDY III   
The design of the M-PRODIA study protocol was guided by input from PWD and 
qualitative data collected during the PRO diabetes development process and aligned 
with the program theory for the PRO diabetes tool. The rationale for the design of 
brief Likert scale PRO evaluation questionnaires was that valid brief questionnaires 
were required, which could be completed by PWD and HCP as part of routine care 
even in study sites with very limited resources for collection of research data. A digital 
user-friendly system was needed with minimal responder burden 93. 
Protocol acceptability and feasibility was optimized through co-design with PWD and 
HCP at each site and local tailoring of procedures as needed for each site. The aim 
was to minimize noise and interference caused by data collection as much as possible. 
As a key goal of the study was to generate data to guide future implementation of the 
PRO diabetes tool, the RE-AIM framework 153 was used to guide data collection and 
analysis plans.  
The study design reflected the realization that both qualitative and quantitative data 
was required to capture and analyze the complexity of real-world usage and 
effectiveness of clinical PRO tools 329.  The PRO evaluation questionnaires were 
designed to quantitatively evaluate feasibility, acceptability, validity, relevance, 
implementation, and perceived effectiveness in line with the hypothesized benefits. 
Wording and content were prioritized in collaboration with people type 1 and type 2 
diabetes.  
3.3. KEY FINDINGS 
3.3.1. STUDY I 
This study revealed that PWD found both objective clinical indicators as well as 
subjective indicators of life impact and care experience to be highly relevant and 
important to include in planned future efforts to evaluate diabetes outcomes.  
The study found the following areas to be required for comprehensive outcome 
evaluation: self-rated health, psychological well-being, diabetes related quality of life 
and diabetes-specific emotional distress, medical treatment experience and burden, 
blood sugar regulation and burden of hypoglycemia, confidence in diabetes self-
management, symptom distress related to neuropathic pain, cardiovascular symptoms, 
sexual dysfunction, sleep and fatigue and gastro-intestinal symptoms and access to 
person-centered diabetes care, support and required technology 1. The core constructs 
were identified as relevant to both type 1 and type 2 diabetes whereas issues pertaining 
to hypoglycemia and blood sugar fluctuations were only relevant depending on the 
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use of insulin therapy and methods for blood sugar measurement. PWD agreed that 
all outcome areas were relevant for all PWD as a lifespan outcome set, with the 
exception of insulin-related treatment burden, since needs of PWD change over time 
17.  
3.3.2. STUDY II 
All PWD regardless of type of diabetes, diabetes duration, age, treatment modality, 
and burden of disease found it manageable and acceptable to complete the diabetes 
PRO questionnaire from home using DiaProfil in connection with their scheduled 
regular visit.  PWD found the questionnaire to be relevant with comprehensive 
coverage of relevant topics and no one reported major concerns or problems related 
to the questionnaire or its use. This was confirmed by combining semi-structured 
interviews, Likert-scale questionnaires, audio-recording of consultations and 
debriefing workshops with health professionals. 
Both PWD and HCP reported that the use of the PRO results using the digital PRO 
diabetes tool was feasible, acceptable and helped improve the quality of the dialogue. 
PWD were positive about the opportunity to fill out the questionnaire in advance and 
many expressed it made them better prepared. They felt reassured that they would get 
to talk about their priority topics at their next visit 2.  
3.3.3. STUDY III  
A complete set of data collection tools and evaluation questionnaires were finalized 
and successfully implemented in all three healthcare settings as part of study III. The 
evaluation questionnaires evaluated subjective experience of PWD of the PRO 
questionnaire’s content, format and purpose and perceptions of impact as well as 
HCP’s subjective evaluations of use of PRO in line with RE-AIM framework 
constructs 330.  
In March 2021 field work was completed by the main study sites: Two ambulatory 
diabetes care clinics at Frederiksberg-Bispebjerg Hospital (Denmark) and Aalborg 
University Hospital (Denmark), five Danish municipal diabetes education centers and 
one primary care clinic. Consolidation of the study database is ongoing at the time of 
submission of this thesis so approximate numbers from the database are provided. An 
interim database was analyzed with data from 560 PWD who had completed informed 
consent and the PRO diabetes questionnaire and 501 PWD who had completed the 
PRO-EVAL-PWD questionnaire which evaluated their experience of the PRO 
questionnaire itself. 31 HCP had completed the PRO-CON-EVAL-HCP evaluation 
questionnaire after a total of 481 diabetes visits using PRO which resulted in detailed 
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data regarding perceived visit quality, clinical validity of PRO data and scoring 
algorithms, utility of the digital dashboard and overall impacts of PRO on the dialogue 
and care quality and the role of the PWD. In the interim database 301 PWD had 
completed the PRO-CON-EVAL-PWD questionnaire to evaluate their experience of 
use of the digital PRO tool during their diabetes visit. 40% of PWD in the study were 
women, approximately 30% were type 1 diabetes, mean age was 57 years. A total of 
4 doctors, 25 nurses, 5 dietitians and 8 physiotherapists took part in the evaluation. 
Distribution and missing value analysis, internal consistency reliability analyses, 
factor analyses and construct validity testing confirmed that the PRO and PRO 
evaluation questionnaire data were usable for protocolized statistical analysis. 55 
semi-structured interviews of PWD were audio-recorded, transcribed and registered 
in NVivo for initial coding and analysis with questionnaire data as part of the M-
PRODIA study. 10 multi-disciplinary evaluation team workshops involving 31 HCPs 
were transcribed and transcriptions were coded and prepared for thematic analysis in 
Nvivo 12. The statistical analysis of final study results is scheduled to be done April-
June 2021 and the main interim results are accepted for congress presentations end of 
June 2021. While the results of study III will be presented and published separately 
through formal future presentations and are not as part of this thesis, some specific 
examples of interim results are provided in this section to illustrate the acquirement 
of substantial useful data using the study protocol developed in study III.  
Examining the interim evaluation data from PWD in the M-PRODIA study, more than 
90% of PWD who evaluated the use of PRO after their visit reported the PRO 
dashboard gave a good representation of their diabetes situation whereas less than 
2.5% did not. 86% of PWD felt that completing the PRO diabetes questionnaire made 
them feel better prepared for the visit whereas 1% indicated feeling less prepared. 
About 95% of PWD reported that the use of their PRO diabetes data in the visit 
resulted in better focus on the topics that were most important to them to talk about. 
99 % of PWD reported they had no unpleasant or uncomfortable experiences related 
to the use of PRO diabetes for their diabetes visit. The majority of PWD reported a 
perception that the PRO diabetes tool had a positive impact on their own diabetes 
management as well as on the ability of their HCP to give better quality diabetes care. 
The qualitative data from the semi-structured interviews of PWD after the PWD had 
participated in a routine diabetes visit which included the use of their PRO data in the 
dialogue were initially analyzed and coded by multiple coders to obtain an initial 
quantification of PWD’s experiences relating to acceptance, comprehension, 
feasibility and perceived value. The initial coding of PWD’s experiences based on 
interviews showed very high concordance with PWD’s responses to the PRO-EVAL 
and PRO-CON-EVAL questionnaires. A full analysis of inter-rater reliability and 
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reliability of the evaluation questionnaires is pending completion of a comprehensive 
coding of all interviews. Analyses of the interview data identified that a subset of 
PWD experienced the process of completing the questionnaire as very positive due to 
the self-reflection process that was prompted. The positive aspects of self-reflection 
were related to a perception that the PRO questionnaire prompted 1) healthy 
consideration of own efforts to manage diabetes and 2) identification of specific 
difficult topics that were important for the PWD to discuss but which the person might 
not have brought up had it not been for the PRO tool. A positive experience was also 
associated with the PWD’s appraisal that the questionnaire was relevant, 
comprehensive, and person-centered 2. These initial findings directly support the 
initial results of study II and quantitative analyses are ongoing to examine which 
patient characteristics are associated with perceived benefits related to questionnaire 
completion and self-reflection. PWD who participated in study III expressed the 
benefits of completing the PRO questionnaire in different ways which is illustrated by 
the following quotes from five different PWD: "the questions are good and sets the 
thoughts in motion", "you are forced to think about your situation", "I think more 
about the importance about taking charge of my diabetes", "it makes me think about 
how it is actually going [with my diabetes]", "I got to reflect about the positive aspects 
– I thought about the fact that it is good that my diabetes is well regulated".  
A contribution of this study is the granular assessment of individual experiences of 
use and value of the PRO diabetes tool which revealed major individual variation in 
personal benefits of using the PRO tool. The PRO questionnaire did not appear to 
benefit PWD who had a high degree of disease mastery as much. Even so, many of 
these PWD still found it valuable to complete the PRO questionnaire because they felt 
it led to a more productive diabetes visit.  
The extent to which PWD had problems related to their diabetes was also see to affect 
their experience and what kind of benefits they experienced as a result of the PRO 
tool. 
DiaProfil is a flexible user-friendly PRO data collection app which allows the PWD 
to choose between mobile, tablet or computer interfaces for self-completion and 
additional features were included based on user testing to decrease cognitive burden 
and improve reliability of measurements. Using different modalities however raise 
methodological challenges regarding congruence and comparability of data obtained 
from different user interfaces. Psychometric analyses will therefore be undertaken to 
examine validity, reliability, and measurement errors across platforms. One brief 
example of initial psychometric analysis to examine data quality is shared here for 
illustration. The interim data for the WHO-5 Well-being Index 143 from 560 PWD 
were analyzed in order to psychometrically compare data collected via the Danish 
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PRO diabetes DiaProfil tool with previously collected population data using both 
paper and web-based forms. The internal consistency of the scale was adequate 
(Cronbach α= 0.83), the mean score in the diabetes population was 60.0 (SD=21, score 
range:0-100) which was in line with expectations (The Danish population norm is 
approximately 70). 30% of PWD had moderate low well-being (WHO-5 score<50) 
and 14% had very low well-being indicative of possible depression (WHO-5 
score<28) which corresponded to other studies. Furthermore, as hypothesized, the 
WHO-5 well-being score was positively associated with self-rated health, daily life 
with diabetes, confidence with self-management and negatively associated with 
diabetes related emotional distress, symptom distress and having general life issues 
interfering with their diabetes management 143,309,331. Overall, the psychometric 
characteristics of the WHO-5 index data were in line with previous WHO-5 diabetes 
research by the author of this thesis and others 7,62,143,331. Approximately 20% of PWD 
exhibited signs of diabetes stress using the global items for distress in the Danish PRO 
diabetes questionnaire and the nature and levels of distress were concordant with 
results from a national Danish diabetes survey which had included items from the 
Danish PRO diabetes items alongside other items 194. Initial analysis also confirmed 
that the diabetes distress items in the PRO diabetes questionnaire were able to 
discriminate between insulin and non-insulin users and people with type 1 diabetes 
and type 2 insulin which was also anticipated. About half of the PWD who exhibited 
signs of diabetes distress had reduced psychological well-being. 9.7% of PWD in the 
national M-PRODIA study sample were indicated to have likely depression according 
to the two-item depression screener (MDI-2 209) in the PRO diabetes questionnaire. 
The relevance of somatic symptom distress was supported by the finding that 19-38% 
of PWD in the national pilot study (interim data) indicated high somatic distress with 
pain (35%), sleep difficulties (38%), gastro-intestinal symptoms (31%) and sexual 
dysfunction (29%) being most commonly indicated. The value of assessment of 
sexual dysfunction was highlighted both by PWD and by HCP and by study sites. In 
some pilot sites the care for sexual dysfunction was markedly improved during the 
pilot testing of the PRO diabetes tool because its use highlighted the need for 
systematic improvements in HCP’s ability to provide counselling and referrals for 
PWD with sexual dysfunction.  
31 HCP (nurses, physiotherapists, dietitians and doctors) participated in the 
MPRODIA study (study III) and completed both baseline and end-of-study 
questionnaire evaluations as well as evaluations of use of PRO diabetes after 
individual care visits. More than 95% of HCP expressed confidence in their ability to 
use the PRO diabetes tool in their diabetes visits which increased significantly during 
the pilot study. The mean confidence score was 4.4 (SD=0.7) on a Likert scale from 
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1-5 with 5 representing high confidence. Initial analysis of qualitative data (free text 
evaluations and transcriptions of HCP evaluation workshops) suggests confidence is 
both related to confidence in ability to interpret the PRO data and to use of the data in 
a good person-centered way during the care visit with the PWD. More than half of 
HCP developed a more positive attitude about the PRO diabetes tool during the period 
of pilot testing and only one HCP reported a slightly negative attitude. At least 85% 
of HCPs experienced that the use of the PRO diabetes tool improved their work 
satisfaction related to caring for PWD, and none reported that it decreased their work 
satisfaction. The perceived impact on work satisfaction was related to feeling better 
prepared for visits and to experiencing a more meaningful and productive dialogue. 
About 1 in 5 of HCP reported some increase in work stress related to usage of PRO 
which appeared to be mainly related to time constraints especially regarding instances 
where the PRO dashboard highlighted many problem areas for the PWD. All HCP in 
the study expressed very strong interest in continuing to use PRO diabetes in their 
care and willingness to recommend the use of tool to other diabetes HCPs. 2 out of 3 
believed it would be essential that HCP receive training in use of PRO in the dialogue 
prior to implementation whereas one third did not believe it was required. Initial 
qualitative analyses found that the perceived requirements for use of the PRO diabetes 
and approaches to use depends on the HCPs care style, diabetes care training and 
experience, specialization, and context of care.  
3.4. METHODOLOGICAL CONSIDERATIONS  
3.4.1. STUDY I 
The context and resource frame for the study necessitated a narrow focus on program 
deliverables rather than research depth, which resulted in the adaption of a pragmatic 
approach to the choice of scope and methodology. The scope was limited to 
identifying broadly defined outcome constructs as following phases of the program 
would focus on measurement. It was not feasible to undertake a preference survey 
involving a larger group of the population as it was out of scope of the study to go 
into detail about patient prioritization of clinical and physiological outcome 
indicators. It was also out of scope of this study to involve different diabetes 
stakeholders in a more in-depth way when it came to the prioritization of outcomes 
for the purpose of identifying more operational outcomes beyond what was possible 
during one working meeting. 
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3.4.2.  STUDY II 
The use of convergent mixed-methods was useful to strengthen the robustness of the 
results, clinical relevance, and interpretability of the study results. It was also useful 
to support the content validity of the Likert-scale PRO evaluation questionnaires. A 
limitation of the study was that there was only one qualitative analysist involved in 
coding and analyzing the data as the HCPs were unable to access the qualitative data 
since patient participants had been explicitly promised their results would not be 
shared with the HCPs (only the author, as a non-HCP qualitative researcher, had 
access to this information). This was done as part of the efforts to minimize bias 
related to social desirability. The study results should be considered in light of its 
pragmatic design and limited scope with focus on feasibility and acceptability testing 
and formative evaluation to provide a basis for the design of the larger study III. 
3.4.3.  STUDY III 
The real-world piggy-back study design has important strengths and limitations. A 
key strength is the systematic collection of both quality and quantitative data which 
detail the experiences of PWD and HCP related to use of PRO in care. This 
experiential data fills important gaps in our current understanding regarding the 
drivers of acceptance and adoption of PRO in practice from the patient perspective 
and the causal pathways by which PRO tools may impact distal diabetes outcomes.  
An important strength of this study is the systematic collection of matching data from 
both PWD and HCP for several hundred diabetes care visits which allows for testing 
of interrater reliability and hypotheses derived from both the PRO tool’s program 
theory and study II. The use of multi-informant data provides for a more robust 
evaluation of perceived impacts of the PRO diabetes tool on patient participation and 
quality of the dialogue 3. Another strength is the use of brief digital evaluation 
questionnaires integrated into the PRO tool and minimally disruptive procedures to 
mimic real-world care as much as possible. It was not in scope for this study to 
document if any concrete changes were made in relation to the individual priorities of 
each PWD based on the use of the PRO diabetes tool. Due to the great individual 
variance in how the PRO tool impacts a PWD, such evaluation requires a 
comprehensive follow-up design which takes into account individual care goals. 
Limitations of the study design include the lack of an attention control group, 
comparison to other PRO tools, longitudinal follow-up and use of objective measures 
for outcome evaluation. These limitations need to be addressed in future research.  
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3.5. DISCUSSION AND CONCLUSIONS 
 
3.5.1. STUDY I 
To our knowledge this was the first study at the time to identify a patient-prioritized 
list of core outcome constructs for diabetes outcomes assessment in Denmark using 
systematic methods for patient involvement and a value-based health outcomes 
framework. 
The finding that the identified priority outcome constructs of general health, 
psychological well-being, perceived life impact of diabetes, symptom distress, 
treatment burden, self-efficacy and access to person-centered diabetes care are 
important to PWD and are relevant to measure psychometrically is supported by other 
research 7. The previous DAWN2 study established a global core set of population 
level indicators of person-centered diabetes care and outcomes through a participatory 
multi-stakeholder process with PWD as partners which was used in a multi-national 
diabetes benchmarking study 7,12. The following patient-important outcomes were 
identified both in DAWN2 and study I: self-rated health, psychological well-being, 
impact of diabetes on life quality, diabetes-related emotional distress, confidence in 
self-management and perceived access to person-centered diabetes care. The DAWN 
study also included measures of empowerment as well as non-professional and 
professional support for healthy coping and self-management as well as a measure of 
perceived discrimination due to diabetes 7. The perception of discrimination was not 
selected as a stand-alone priority outcome construct in study I which may be explained 
by a relatively lower rate of discrimination in Denmark 7,332. PWD did however 
highlight challenges related to lack of knowledge about diabetes among their friends 
and the public.  The factors related to empowerment and specific sources of support 
outside of the healthcare system were also identified by PWD in study I but were not 
prioritized as stand-alone outcomes. These issues may therefore still be deemed 
relevant for incorporation in future efforts to develop outcome measurement models. 
The national Swedish PRO diabetes questionnaire program 263,333 conducted extensive 
qualitative research to establish a national PROM for use to measure patient-centered 
diabetes outcomes in diabetes care. The finalized Swedish diabetes questionnaire 
measures several constructs which correspond to a large extent with the constructs 
identified in study III to be relevant in Denmark: General well-being, depression, 
diabetes related stress, perceived limitations due to diabetes symptoms, worries of 
hypo- and hyperglycemia, confidence in self-management, sleep quality, satisfaction 
with medicine and technology, and support from and access to HCP 263,333. The 
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similarity of findings is important as Denmark and Sweden would be expected to have 
comparable conditions for managing and living with diabetes. The Swedish diabetes 
questionnaire does not include symptom distress related to neuropathy, sexual 
dysfunction, and gastrointestinal symptoms and  hypoglycemia unawareness, which 
were identified as relevant for both PWD and HCP in Denmark in study I-III.  
The project to define a global diabetes outcomes measurement standard set of the 
International Consortium for Health Outcomes Measurement (ICHOM) which was 
co-authored by the author of this thesis identified many of the same outcome 
constructs as we found in study I as patient-important outcomes. This included well-
being, depression, diabetes related distress, treatment burden, hypoglycemia and self-
management. The scope and aims of the ICHOM program differed from both the 
Danish and Swedish programs as ICHOM’s aim was to define outcome tools for 
global use with focus on passive use of outcome data to monitor and benchmark 
quality of diabetes care and with limited focus on the clinical dialogue. Due to 
pragmatic requirements for selection of questionnaires with global accessibility and 
usability, the WHO-5 Index 143, PHQ-9 304, and PAID 126 were selected as the 3 
PROMs to be included in the global ICHOM standard set 86. These PROMs measure 
psychological well-being, depression, and diabetes related emotional distress, 
respectively. While the 20-item PAID questionnaire covers issues that are relevant to 
PWD and their clinical care 126,334, it does not include several constructs that were 
identified as important to PWD in our study such as daily life with diabetes, 
confidence with self-management, treatment satisfaction, subjective evaluations of 
blood sugar regulation and somatic symptom distress. The PAID questionnaire 
measures severity of problems and does not provide options for PWD to indicate 
positive experiences related to daily life with diabetes, self-management, support, and 
treatment satisfaction. Findings from our patient involvement process suggests that 
the PAID as a standalone tool does not provide sufficiently broad coverage of the 
outcome constructs that are important to PWD in Denmark. The ICHOM working 
group identified the relevance of additional outcome constructs in the design process 
including those identified in our study and encouraged consideration of supplemental 
PRO assessments if relevant. Our study identified a core set  of outcome constructs of 
importance to PWD which are supported by the wider literature as relevant for clinical 
use. The research team identified the following as the most useful strategies for patient 
involvement in study III: 1) the involvement of PWD in the early planning and design 
of the patient involvement activities, 2) the use of theoretical purposive sampling, 3) 
the pragmatic use of qualitative research methods to augment use of data and 4) the 
consideration of best practice principles to ensure a good process experience. The high 
level of concordance between the diabetes outcome constructs identified as important 
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by PWD and the resulting core set determined by the multi-stakeholder consensus 
process suggests that the research project was responsive to the patient perspectives 
and priorities 1. While a formal scientific evaluation of the impact of the patient 
involvement was not undertaken specifically for study III the research team found that 
the use of systematic methods facilitated transferability, credibility and impact of the 
patient involvement process. 
3.5.2. STUDY II 
The qualitative data indicated that completion of the questionnaire may be a positive 
reflective experience for a subset of PWD which can facilitate active participation in 
care independent of effects of use of PRO diabetes by the HCP in the visit. The study 
suggests that the positive experiences reported by some PWD related to completing 
the PRO questionnaire may be related to key user friendly, person-centered features 
of the questionnaire which were defined by PWD in the development process. PWD 
praised the user friendliness, the wording of items, the absence of questions that can 
be perceived as “pointed fingers”, and expressed they felt all main topics were well 
covered by the questionnaire. These were all factors that had been explicitly addressed 
as a result of the systematic approach to patient involvement in the design of the PRO 
questionnaire. It is hypothesized that the perceived positive experience related to 
completing the PRO questionnaire is partly due to questionnaire qualities resulting 
from patient involvement in the design: person-centered language, patient-perceived 
relevance, comprehensive topic coverage, balance of negatively and positively 
worded items and consideration of both problems, resources and action options. Some 
PWD reported a positive experience from completion whereas others did not and it 
appeared that the individual situation of the PWD, e.g. level of current mastery of the 
disease, was a key determinant. Furthermore data suggested that the extent to which 
the PWD understood the intended use of the PRO questionnaire (e.g. to improve the 
quality of the dialogue by focusing on what matters most to the PWD) had a major 
impact on the potential for the PWD to have a positive reflective experience. 
Optimizing the patient experience related to filling out the PRO questionnaire is 
important not only from a therapeutic perspective but as a way to motivate PWD to 
attend visits and participate in care and to improve the care experience for PWD. The 
latter is of high importance since PWD undergo treatment across their lifespan and it 
was shown in study I that the experience of person-centered, respectful and emphatic 
diabetes care is a priority outcome for PWD in its own right. 
The study showed that the use of the PRO diabetes tool affected the content of the 
dialogue and directed the focus of the dialogue to the topics highlighted by the PWD 
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in advance as most important. The qualitative results provide a basis for hypothesizing 
that the use of the PRO diabetes dialogue tool in the visit increases the proportion of 
time during the dialogue which focuses on what is of greatest diabetes-specific 
importance to the PWD 58.  
It was an important finding that many broader health-related constructs were actively 
and concretely used to support the dialogue, including general life issues impacting 
diabetes (economy, co-morbidity, stress), general social support, self-efficacy and 
confidence in access to care. While some of these constructs are not directly 
modifiable by HCP action, our study supported the potential importance of their 
inclusion for facilitating health-related empowerment 45, self-efficacy 204, and 
potential adoption of a whole person approach 328. The importance of a broad coverage 
of topics is also supported by research demonstrating the value of considering the 
complex interactions between biological, psychological and social factors as 
perceived by PWD in order to support healthy coping with diabetes 335 . 
The effective use of the question on general life situation issues impacting diabetes 
provided initial indications that these constructs function well as part of a broader 
approach to diabetes care based on a social ecological model2. Many PWD reported 
that they had general life situation issues (e.g. work, economy, other health problems) 
which had a moderate (51%) and major (9%) negative impact on their ability to 
manage their diabetes. HCPs reported the item was useful and relevant in the dialogue. 
The specific wording had been adjusted during user testing in dialogue with PWD and 
HCP to ensure it captured the right construct. Initial results suggest that the 
incorporation of broader health constructs including social determinants may be 
beneficial for optimizing the use of PRO tools within a person-centered and whole 
person care model 63. The evaluation of use of each PRO construct by PWD and HCP 
in this study is only exemplified here. The analyses provide initial proof-of-concept 
for their usefulness to prompt topics in the dialogue and contribute to the overall 
review of the PWD’s diabetes situation. Our findings are line with other research 
showing positive impacts of use of digital PRO tools on the patient’s experience of 
person-centered care 4,328. 
Several PRO diabetes tools provide stand-alone assessment of the individual’s mental 
health 27,29,137,208,336 and diabetes related distress 86,337 in order to ensure early detection 
and treatment of mental health disorders and improved care for emotional problems 
related to diabetes27,61. The Danish PRO diabetes tool includes items that measure 
psychological well-being 7,143,149,208, depression 209, diabetes related distress 18,19,137,217–
222, and aspects of diabetes-related impact on life 19,223  as elements of a broader 
assessment of a range of health-related constructs. Our study results suggest that the 
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nesting of these items within a broader set of constructs and items provided an 
effective and helpful context for detecting and prompting depressive symptoms and 
diabetes-related distress when this was relevant. 
The PRO diabetes tool evaluated confidence with self-management and priorities for 
self-management support using the theoretical model for measurement of self-efficacy 
as the basis 67,69,227–236. The study results suggest the measurement of confidence with 
self-management is helpful as a part of the dialogue about individual diabetes 
education needs as also indicated by other research 65,192,231. The study supported the 
potential clinical utility and relevance of diabetes-related somatic symptom distress 
237,238,309 which was included in concordance with study I 1 and in line with other 
research supporting clinical relevance and measurability of pain 239–241, 
gastrointestinal symptoms 19,242–246, cardiovascular symptoms 238, sexual dysfunction 
distress 19,247–250, sleep difficulties 130,251–256 and foot problems 260–262. Burden of 
hypoglycemia and challenges with blood sugar regulation were identified and 
discussed using the PRO diabetes tool in the study and the broad usage was further 
corroborated in study III confirming high relevance and utility especially in PWD 
using insulin. The relevance of measurements of patient experiences related to blood 
sugar regulation and hypoglycemia was established in study I 1, during the 
participatory PRO tool development process and is supported by related 
research7,13,18,20,21,222,234,250,256,287–293.   
It was a general observation in this study that the specific content and format features 
of the PRO diabetes tool which were a result of the involvement of patients in the 
design stage were positively evaluated by PWD during the pilot testing. This related 
to both the constructs and wording of questions. For example, PWD expressed 
appreciation of the fact that the questionnaire did not raise “pointed fingers” and 
balanced neutral and negatively focused questions, which were specifically 
emphasized by PWD during the design phase. All PWD found the questionnaire’s 
coverage of topics relevant and comprehensive. Further assessment of this will be 
undertaken as part of a systematic analysis of positive and potentially negative effects 
of patient involvement across all stages of the PRO diabetes questionnaire program. 
3.5.3. STUDY III 
The M-PRODIA study protocol was designed to collect new structured quantitative 
and qualitative data to allow for testing and further development of the program theory 
(table 5) and conceptual working models for use in different care settings.  A 
simplified conceptual working model defined based on study II, the participatory PRO 
diabetes tool design process and related research 4,156,290,338 is shown in figure 2.  
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Figure 2. Simplified conceptual working model for the PRO diabetes tool. 
The interim results of study III provide initial corroboration of results from study II 
which suggest that some of the benefits of the PRO diabetes tool experienced by PWD 
may be mediated by self-reflection (self-insight and disease insight), motivation and 
active participation in diabetes care. Interim study results were used to begin to define 
hypotheses for how the PRO diabetes tool may support each of four key steps68,69 of 
patient empowerment. Table 8 shows examples of hypotheses that are based on initial 
results from study II and III pertaining to the value of reflection. The significance of 
the reflective process and the utility of this in the dialogue process has been described 
as part of a model for person-centered care and guided self-determination 56. It may 
be hypothesized that the use of the PRO diabetes questionnaire can facilitate the 
PWD’s autonomous re-assessment of own care needs and options 58. The initial 
hypothesis pertaining to the potential benefit related to the fourth element of 
empowerment listed in table 8 is based on tentative data from study III which showed 
that PWD were motivated and enthusiastic about the ability of the PRO diabetes tool 




Examples of hypothesized impacts of PRO diabetes on 
aspects of empowerment for PWD. 
1) Understanding 
the personal 
The self-completion of the Danish PRO diabetes 
questionnaire increases the PWD’s self-awareness and 
understanding of personal biological, psychological and 
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experience of 
impact of diabetes. 
social impacts of diabetes and related personal support 
needs. 
2) Understanding 
preferences for own 
role in diabetes 
care. 
The self-completion of the Danish PRO diabetes 
questionnaire makes PWD more aware of their own role in 
their care and their preferences for how they would like to 
be involved in their own care. The PRO diabetes tool 
exerts its effect by inviting the PWD to set the agenda and 
signaling respect for and acknowledgement of the role of 




goals and needs 
PWD gain self-insight regarding own self-management 
practices and priority goals for self-management through 
the self-completion of the PRO diabetes questionnaire. 
This enables the PWD to more actively communicate 
personal self-management goals and support needs and 
more actively take part in collaborative care planning. 
 
4) Use of trial and 
error to find better 
individual strategies 
for living well with 
diabetes. 
The introduction of dynamic monitoring of patient-
important outcomes engages PWD to continuously 
explore, evaluate and improve personal strategies for 
diabetes self-management. 
Table 8. Examples of hypothesized links between the PRO diabetes tool and 
empowerment. 
The combined results of study II and III provided detailed insights into the 
experienced impacts of use of PRO on the quality of the dialogue. The impacts on the 
dialogue appeared to differ depending on the characteristics of the care setting, the 
format of the visit, and individual characteristics of both the HCP and PWD.  
The potential for improvement of both self-insight and disease insight resulting from 
PRO diabetes to facilitate active participation shown in study II was confirmed in 
study III. 
Study II and III provided data to help identify individual and organizational factors 
that may influence adoption196 of the PRO diabetes solution by HCP in routine care. 
In line with behavior change theory, HCP adoption may be expected to be predicted 
at the individual level by self-efficacy, motivation and perception of 
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barriers/opportunity related to use of PRO diabetes 161. The finding that all HCPs were 
highly confident in own ability to use the PRO diabetes tool in study III and that 
confidence increased over time suggests confidence may contribute to high level of 
adoption.  High confidence is hypothesized to be mediated by HCP’s ability to use 
PRO diabetes for person-centered priority-setting and care planning, clear roles and 
responsibilities regarding how to use and follow-up on PRO results, and simplicity, 
user-friendliness, relevance and appropriateness of the PRO dashboard. The HCP in 
study III were highly motivated to continue using the PRO diabetes tool after the pilot 
study. High motivation is hypothesized to be partly caused by the improved work 
satisfaction experienced as a result of PRO diabetes. Qualitative data suggest that 
improved work satisfaction relates to the perception of improved meaningfulness and 
effectiveness of the dialogue with PWD, improved interpersonal relations with PWD 
and PWD’s experience of satisfaction with the encounter. Our findings regarding the 
impact of PRO on HCP’s work satisfaction represent a new important field of research 
which can now be analyzed further. The relevance of the well-being and satisfaction 
of the HCP who provide diabetes is highlighted by emerging research describing 
diabetes stress among HCP 339. 
Adoption of the use of the PRO dashboard in care visits also requires that the HCP 
has the practical opportunity to adopt PRO diabetes in practice and that specific 
barriers can be identified and overcome. This means that adequate PRO practice 
facilitation 340  which helps each clinic or care team to identify and address local 
barriers to integration of PRO diabetes in routine care is important 192. 
3.6. STUDY IMPLICATIONS AND NEXT STEPS 
3.6.1. STUDY I 
Study I involved PWD in the scoping phase of the national value based diabetes 
program 181. The study identified the importance of measuring mental health, diabetes 
impact on quality of life, treatment burden, somatic symptom distress, confidence in 
self-management, and experience of person-centered relationship-centered diabetes 
care using a social ecological framework 5,96. The implications of the study is that the 
agreed patient-important outcome constructs need to be operationalized so they can 
be standardized and harmonized nationally and potentially internationally96. As 
diabetes language, culture and treatments change, many existing PRO diabetes 
questionnaires become outdated raising the demand for harmonization at the level of 
latent diabetes outcome constructs. While it is widely agreed that measurement of 
positive psychological well-being can be done with e.g. the WHO-5 Index 143, precise 
SKOVLUND: THE USE OF SYSTEMATIC APPROACHES TO PATIENT INVOLVEMENT IN THE DEVELOPMENT AND 
EVALUATION OF A PATIENT REPORTED OUTCOMES TOOL FOR USE IN ROUTINE DIABETES CARE. 
78 
definitions of latent constructs to be measured in relation to diabetes-related quality 
of life 78,96, diabetes-related emotional distress 22,341, and other PRO constructs 79 are 
lacking. Our study emphasizes the importance of further research with involvement 
of PWD as partners to establish theoretically grounded and carefully defined latent 
outcome constructs to be used for diabetes outcome measurement which takes into 
account a social ecological approach and personal resources 70,96. 
3.6.2. STUDY II 
Methodological research is needed to evaluate and further document the usability of 
the pragmatic multi-informant methods applied to examine clinical validity, utility 
and person-centered impacts of PRO in clinical practice. Development of standard 
methods to integrate qualitative and quantitative evaluation data for clinical PRO 
testing as done in this study could benefit future clinical PRO research 342.  
The study provided initial support for face validity and clinical utility of the PRO 
diabetes tool. Given the broad topic coverage of the questionnaire and use of 
branching logic, clinical testing of the full PRO diabetes questionnaire requires a study 
with a larger population as was undertaken in study III. 
The findings of study II suggest that using a PRO questionnaire which covers all main 
topic areas perceived as important by PWD may be beneficial for PWD due to the 
value of the reflective process. It may be hypothesized that the perceived benefit by 
PWD is partly dependent on the comprehensiveness of the PRO diabetes 
questionnaire coverage.  
Future research could compare how completing different PRO diabetes questionnaires 
(different topic coverage and length) impact PWD’s experience of benefits related to 
self-reflection and overall impact their preferences. Further research is needed to 
examine which individual PWD characteristics predict if the PRO questionnaire is 
perceived as valuable due to self-reflection. This can be tested using study III data. 
3.6.3. STUDY III 
Given the highly positive interim results for study III controlled research studies are 
warranted and could potentially use a stepped wedge343 effectiveness study design to 
evaluate the clinical, PRO and health economic impacts of the PRO diabetes tool 
across healthcare sectors. This will create the needed evidence to guide future policy 
decisions regarding expansion and ongoing improvement of the program.  
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3.6.4. PAPER IV  
The results of the paper highlights a need for development of a broader theoretical and 
methodological framework for the use of PRO to improve aspects of person-centered 
diabetes care. There is a need to reconcile the many different models for use of PRO 
in clinical practice and develop a methodological framework which can facilitate 
international harmonization and collaboration. Systematic patient involvement and 
strategies for contextual and participatory learning 182 as well as mixed-methods 
research 159 will be important methodological approaches to incorporate in ongoing 
psychometric clinical PRO diabetes research. 
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CHAPTER 4. PRACTICAL AND 
RESEARCH IMPLICATIONS  
4.1. CONTRIBUTIONS TO DIABETES CARE AND OUTCOMES 
The research in this thesis contributed significantly to the development of the first 
nationally agreed upon Danish PRO diabetes questionnaire and a new clinical digital 
PRO tool, DiaProfil. The use of the PRO diabetes tool has been shown to be highly 
acceptable for use in routine care by both PWD and HCP and is now available and 
approved for use nationally to improve the quality of diabetes care in both hospital 
and municipality care settings. Initial data from the research studies in this thesis and 
unpublished data support the findings of the national health data authority’s evaluation 
report 2021, which shows that using the PRO tool results in PWD feeling better 
prepared for their visit and leads to diabetes visits becoming more meaningful and 
relevant as they focus more on the most important issues for the PWD. Importantly, 
the national PRO diabetes pilot study indicates that integration of the PRO diabetes 
tool in standard care within existing health care resources is feasible. 
The newly developed digital PRO diabetes tool, DiaProfil is a result of this research, 
and introduces a new important functionality that may improve diabetes care in the 
future. The DiaProfil solution provides the HCP with one-click access to concrete, 
locally relevant information about relevant follow-up options for each PRO topic 
which is intended to facilitate improvements in the way HCP help PWD navigate their 
full range of support options across the care continuum. The strategic adoption of this 
functionality by the health authorities across health systems holds the potential to 
significantly increase the appropriate use of the full range of diabetes care, education, 
community, technology, social and public service offerings available to PWD. Such 
an effort could be potentially based on the nationally standardized assessment of needs 
of PWD introduced by the PRO diabetes tool. Linking referrals and care pathways 
more directly to PRO could help minimize waste, monitor value, and strengthen the 
role of HCP as gate keepers of resources from a whole-person care approach.  
While it is an important value contribution in its own right that PWD experience that 
the PRO tool is helpful to them and improves the quality of their dialogue with their 
HCP, it is a necessity to pursue detailed assessment of causal relationships between 
use of the PRO diabetes tool and factors such as satisfaction, health-related 
empowerment, self-management, quality of medical care and education and health 
and quality of life outcomes now. This will help guide future investments to ensure 
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the appropriate and evidence-based use of PRO tools in the future. A multi-
disciplinary health services research platform is required in Denmark which is 
designed for the complex task of quality assurance and evaluating the effectiveness of 
PRO within and across diseases.  
Many of the hypothesized or intended benefits of the PRO diabetes tool rely on the 
implementation of supportive strategies which may or may not be implemented. It is 
therefore important that future PRO evaluation research in Denmark adopts a 
systemwide view on the role PRO tools can play in achieving patient-orientated 
objectives. As an example, the PRO diabetes tool incorporates screening questions for 
depression and diabetes-related distress in line with evidence-based recommendations 
27. Improving screening and early detection in routine care has the potential to improve 
mental health, psychosocial as well as clinical and health outcomes 27,344 but only if 
implemented as part of a coordinated strategy that ensures that adequate psychosocial 
care, support, and resources are available 61,345. The development of PRO evaluation 
methods for use in real-world settings in this thesis provide one starting point for 
defining viable models for ongoing evaluation of PRO. 
The Danish PRO diabetes tool was created as a result of a creative co-learning process 
involving PWD, FM, HCP, researchers, and other health stakeholders and constitutes 
a new innovative intervention model for use of PRO in routine care in Denmark.  
This means that we are presently at the bottom of a steep learning curve in terms of 
understanding the tool’s full potential, its advantages and disadvantages, and the main 
facilitators and barriers to effective implementation. 
The national implementation of the PRO diabetes tool in Denmark may result in 
general improvements to participation of PWD in care and dialogue quality in 
Denmark. Furthermore, if national efforts are undertaken to ensure implementation of 
the PRO diabetes tool in close coordination with other person-centered care policies, 
it is possible that several derived benefits may be achieved from introducing the tool. 
Possible additional benefits that may be achieved by implementing PRO on a national 
scale in a systematic manner might include: 
1) Positive shifts in public awareness and attitudes about the role of PWD in care. 
2) Improved multi-disciplinary cross-sector collaboration for person-centered care 
based on relationships established in the PRO diabetes development program 4,39,42. 
This assumes continued involvement of stakeholders in the implementation 63,176.  
3) Improvements in person-centered diabetes communication 54 between PWD, 
between PWD and FM, between PWD and HCP, and between HCP and HCP as a 
result of the introduction of a new “vocabulary” for patient-important diabetes 
constructs by PRO diabetes.  
4) Normalization and destigmatization of mental health and psychosocial problems 
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related to having diabetes and improved integration of these aspects in health 
promotion, prevention and care strategies across the care continuum.  
5) Increased use of local and national PRO data to identify gaps between patient needs 
and available services to guide quality improvement and service development. 
6) Implementation of value-based diabetes care to generate more health value by 
continuously identifying what care generates most value. 
 
Figure 3 shows a simplified logic model for how the PRO diabetes model may 
influence health care and care outcomes through both passive and active uses of PRO 
data. Future efforts to implement the PRO diabetes tool for different purposes should 
always continue to be done in a participatory manner with PWD as equal partners. As 
supported by this thesis, patient involvement is a critical component in all aspects of 
diabetes care research, intervention design, ongoing quality assurance and care 
improvement. 
 
Figure 3. General logic model for potential benefits of the PRO diabetes program.  
Active use of PRO refers to use of individual PRO data in the individual care for the 
PWD. Passive use of PRO refers to the analytical use of aggregated PRO data. 
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4.2. IMPLICATIONS FOR CLINICAL PRO RESEARCH 
The research in this thesis was pragmatically designed to guide the development of a 
new national PRO diabetes questionnaire and a new digital dialogue tool, DiaProfil, 
for routine clinical use through use of patient involvement and stakeholder 
participation. The result is a final PRO diabetes tool which is now being implemented 
in routine ambulatory diabetes care at the Aalborg University Hospital.  
The collection of structured PRO and PRO evaluation data allows for quantitative 
testing of hypotheses identified during the design and formative evaluation research 
phases 3. Both quantitative and qualitative research can now be used to test hypotheses 
and begin to build causal models and develop the conceptual model.  
The main hypothesis generated by the research in this thesis is that PRO diabetes 
improves the quality of the PWD-HCP dialogue by helping both PWD and HCP to be 
better prepared and facilitates person-centered priority setting. It is furthermore 
hypothesized that the PRO diabetes tool will specifically improve detection and 
person-centered consideration of psychosocial and behavioral challenges of PWD as 
an integral part of their care. If detection of psychosocial problems is adequately 
followed up by systematic referrals and psychosocial support services, improvements 
in mental health, diabetes-related quality of life, health outcomes, and costs related to 
diabetes may be achieved. Furthermore, it is hypothesized that the PRO diabetes tool 
can facilitate a positive shift in HCP attitudes, skills and care practices related to 
treating the whole person with diabetes by using person-centered communication 
strategies and shared decision-making which may benefit patient empowerment, 
health and quality of life of PWD. 
It is hypothesized that the PRO diabetes tool engages PWD to become more actively 
engaged in their own care as a result of multiple influences. It is also hypothesized 
that a significant subset of PWD benefits from self-reflection regarding diabetes 
resulting from completing the PRO questionnaire. This effect is hypothesized to 
depend on the individual characteristics of the PWD and be facilitated by the unique 
comprehensiveness and patient-centered wording of the PRO questionnaire. It is 
hypothesized that increased patient participation is also facilitated by the way the PRO 
diabetes tool legitimizes that the PWD contributes with detailed input prior to the visit.  
The studies demonstrate ways by which systematic patient involvement in each stage 
of development of a PRO tool for clinical use appear to benefit the research process 
and propose specific methods to improve person-centered design of clinical PRO 
tools. The conceptual model for involvement of patients in the design of PRO tools 
assumes that the benefits of patient involvement (research relevance and quality, cost-
efficiency and potential impact on patient-centered outcomes) is derived from the 
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active use of patients’ experiences, perspectives, and co-learning across stakeholders 
at each research stage 176. 
The collection of data from patient involvement activities across all steps of 
development and systematic coding and analysis of these using Nvivo allows for 
testing of specific hypotheses regarding how patient involvement benefits each phase 
of clinical PRO tool design 176,346,347.   
4.3. RECOMMENDATIONS FOR PATIENT INVOLVEMENT IN 
DESIGN OF CLINICAL PRO TOOLS 
The scientific analysis of benefits of patient involvement at each stage of the 
development of the Danish PRO diabetes tool will be initiated in April 2021 upon the 
completion of the final patient workshops. The results of this research will be used to 
define evidence-based recommendations for patient involvement in the design of PRO 
tool for clinical use. The key methods for systematic patient involvement that were 
developed and applied in this thesis are summarized in table 9. Initial results, 
including ongoing feedback from participants and interim results from study III 
suggest that this overall approach to patient involvement was helpful and effective.  
It is recommended to adopt best practices for patient involvement in research4,176,181, 
and apply relevant evidence-based strategies for use of qualitative research333,348. It is 
also recommended that multi-stakeholder participation in research 167,170,171, 
psychometric PRO design 128, health intervention design 202, behavioral and health 
psychology research 63, and public health research 349 methods be prioritized.  
Recommendation Methods used in relation to the Danish 
PRO diabetes tool and this thesis 
Define a patient-orientated 
outcome goal for the PRO 
design process 
The adoption of patient-important measurable 
goals from outset (project aims) (table 5). 
Use quality guidance for patient 
involvement from project start 
161,181,350.  
The adoption of the 7 quality criteria for 
patient involvement 181 in this thesis (table 3). 
Pragmatic use of qualitative and 
mixed-method research methods 
(reflexivity, design, analysis and 
reporting methods) to augment 
patient involvement 351 
The use of qualitative methods to support 
credibility, transferability, reporting and 
impact of patient involvement in PRO 
research (studies I-III).  
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Plan patient involvement for 
each distinct phase of clinical 
PRO tool design 
Use of patient-involvement activities tailored 
to the key steps of clinical PRO tool design 
(table 2). 
Ensure multi-stakeholder 
participation augments impact 
of patient involvement 
The strategies used for multi-stakeholder 
participation in this thesis (table 4). 
Develop conceptual PRO model 
which aligns with available 
empirical evidence and 
theoretical frameworks for 
disease-specific person-centered 
care. 
Use a conceptual model for the PROM which 
is aligned with a disease-specific person-
centered care model 5 and reflects the wider 
evidence base for patient-important outcomes 
1,7,86. Apply a measurement model which 
aligns with the PRO tools’ program theory. 
Develop the PRO tool for 
optimal sustainable, public 
health impact. 
Adoption of the RE-AIM framework to 
consider public health impact of the PRO tool 
in both design and evaluation (study III)63. 
Table 9. Systematic approaches to patient involvement in clinical PRO tool design. 
On a practical level, PRO researchers may consider the following questions when 
selecting PRO tools for use in clinical care to promote person-centered care: 
 
• How were patients involved in conceiving, designing, evaluating, implementing 
and confirming quality assurance of the PRO tool? 
• What are the patient-important measurable goals with the use of the PRO tool?  
• What are the hypothesized mechanisms of action for the PRO tool?  
• Does the conceptual model for the PRO tool align with a broadly accepted 
empirically based framework for person-centered care for the given disease?  
• How was it established that the PRO tool has comprehensive coverage of the 
topics that are considered essential and important to patients? 
• What steps were taken to ensure the PRO questionnaire uses language that reflect 
the lived experience and facilitates respectful, collaborative person-centered 
care? 
• How was it evaluated if the PRO questionnaire is acceptable to patients and 
benefits patients? 
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4.4. RECOMMENDATIONS FOR FUTURE RESEARCH 
While preliminary results from the MPRODIA study support the acceptability and 
utility of the PRO diabetes tool, controlled studies are needed to quantify the effect of 
the PRO tool on care quality, clinical, quality of life, and health economic outcomes. 
Quantitative analyses are also needed to fully detail its psychometric characteristics. 
Both controlled and comparative study designs need to be undertaken to demonstrate 
effectiveness in terms of health and cost outcomes and delineate the most active 
components in order to continuously improve the tool and its implementation 176.  
It is important to examine the “dose-response” relationship, i.e. the relative 
effectiveness of small vs larger PRO tools.  
Mixed-method research155 is needed to do exploratory research and to test the 
hypotheses regarding the impacts and the mechanisms of action of the PRO diabetes 
tool which have been defined in this thesis based on initial data.  
Future PRO research should be multi-disciplinary and acknowledge the need of 
drawing on several different theoretical frameworks to fully evaluate all facets and 
multi-level impacts of the PRO diabetes tool. Psychosocial support in diabetes 27,352, 
individualized self-management and goal-setting 65, diabetes self-management 
education and behavior change 295, person-centered diabetes care5,23, person-centered 
outcomes measurement 86,132, personalized care25, patient empowerment 45, a whole-
of-society model of care  29,39,49 and a sustainable public health 153 approach to diabetes 
care improvement are all research fields with important contributions to the future 
research on PRO diabetes. 
Psychometric analysis of the content validity, reliability, interpretability, and 
responsiveness of each item, scale, latent construct and the overall measurement 
model using large quantitative datasets is required in order to enable the analytical use 
of PRO diabetes data for value-based care and quality of care monitoring 86,99. This 
involves detailed analysis of the comparability of local conditions for questionnaire 
administration and a range of potential contextual and individual sources of 
measurement bias which needs to be investigated. The incorporation of PRO data into 
the patient’s electronic patient record for multi-disciplinary care team use, and the 
experience of patients that the HCP follows up on individual PRO results in 
accordance with certain thresholds comprise potential new sources of measurement 
bias compared to the anonymized administration of PROMs for research purposes. As 
the PRO diabetes tool is implemented, ongoing measurement reliability research is 
needed with systematic patient involvement to examine the level of measurement bias 
caused by factors such as expectations to care and use of PRO data and previous 
experiences. PWDs’ use of both mobile, tablet and PC interfaces to complete the PRO 
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questionnaire and the use of different IT methods by different care settings pose 
significant measurement challenges yet to be researched and documented in detail as 
data is not yet available to document measurement equivalence 353. 
Future research should examine the reach of the PRO diabetes intervention to 
vulnerable populations with specific consideration of equity and overall public health 
impact potential. This involves working with representatives of vulnerable 
communities to understand barriers to using the PRO diabetes intervention and 
strategies for ensuring all people with diabetes can achieve equal benefit of the 
principles of the intervention. It is important to define the optimal target group and 
realistic targets for the PRO diabetes intervention and define suitable alternative 
strategies for providing similar benefits to hard-to-reach populations. 
Many interventions have been developed to support patient activation and aspects of 
person-centered diabetes care over the past decades, but the majority have failed to 
become an integral part of standard diabetes care. Two possible reasons for this are 1) 
Development of the tool in a research environment which is unattached from the 
realities of routine clinical care, and 2) Overreliance on a single theoretical model or 
methodological framework which does not reflect the complexities involved with 
designing a tool for standardized use across health care settings on a national scale.  
In light of the results of this thesis, it is proposed that future research aimed at 
developing and evaluating PRO tools for use in clinical practice should adopt an inter-
disciplinary research framework which is theoretically grounded in the principles of 
patient involvement and participatory research in health care design. To meet the 
requirements of creating a PRO tool that is feasible and value-adding in diverse health 
care settings a broad research framework is required which allows for the integration 
of multiple theories related to the many facets of person-centered diabetes care, health 
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CHAPTER 5. CONCLUSIONS 
Study I found that to evaluate outcomes of diabetes care in Denmark in a way that 
reflects the priorities and perspectives of people living with diabetes, clinical outcome 
indicators should be complemented by self-reported health status, psychological well-
being, and perceptions of impact of diabetes on quality of life, diabetes related 
emotional stress, treatment burden, confidence in self-management and access to 
person-centered quality diabetes care and support.  Study II demonstrated that the 
PRO diabetes intervention was feasible and acceptable to use in routinely scheduled 
diabetes care visits. PWD felt better prepared as a result of completing the 
questionnaire and the use of the digital PRO tool helped improve the quality of the 
dialogue by facilitating identification of and focus on diabetes related issues which 
were most important for PWD. Study III comprised of the design of a national study 
protocol for examining patient and HCP experiences of PRO using the RE-AIM 
framework. Digital Likert-scale evaluation questionnaires were developed to facilitate 
quantitative testing of hypotheses generated from the program theory for the PRO 
diabetes tool and study II. Initial results from study III confirm high acceptability, 
feasibility and perceived benefit of the PRO diabetes tool. The finding that all HCP 
were confident in their ability to use the PRO tool in a good way in routine diabetes 
visits with limited or no additional resources and almost all PWD reported a positive 
experience suggests that the PRO diabetes tool may have a high potential for large 
outreach and public health impact. It may thereby provide important benefits 
compared to more specialized tools for person-centered diabetes communication 
which require extensive HCP training and experience-based learning. 
As implementation proceeds, it is essential that PWD and HCP continue to be 
involved as equal partners to help ensure that the PRO tool is used optimally and 
continuously optimized to improve care practices and patient outcomes. Patient 
involvement needs to continue and be systematic at all levels5,29 to ensure HCP 
training, reorganization of care pathways, community and peer support resources, 
diabetes care policies, national PRO policies, and IT strategies are sustainable. 
The aim of the research presented in this thesis was to involve PWD as partners in 
developing a novel value-based digital PRO tool for routine person-centered diabetes 
care for large scale implementation. Initial data supports that the PRO diabetes tool 
can deliver the intended benefits and has the potential for high reach and adoption in 
the Danish health care system. In addition, the thesis has generated new 
methodological approaches and tools for collection and analysis of quantitative and 
qualitative data. The results of the thesis provide the foundation for the future 
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establishment of a broader theoretical foundation and generic methodological 
framework for person-centered design of PROs for use in routine care for chronic 
diseases. 
It is important to emphasize that the PRO diabetes tool is only “a tool”. To realize its 
full potential, it needs to be implemented as an integral part of a broader sustained 
multi-stakeholder effort for value-based person-centered diabetes care.  
It is my hope that this thesis will inspire future theoretical and methodological work 
aimed at improving patient involvement in the development and implementation of 
digital PRO tools for use in routine care settings across disease areas. 
 
And it is my hope that the results of this research will help enable people with diabetes 
in Denmark to increase their control over, and to improve, their health and quality of 
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The thesis consists of 3 studies which make up a key part of the scientific develop-
ment of the national Danish Patient Reported Outcome (PRO) diabetes question-
naire and the digital PRO diabetes tool, DiaProfil, for use in routine diabetes care. 
The thesis focuses on the use of systematic patient in-
volvement in the development of the PRO diabetes tool. 
The first study concluded that self-reported health and psychological 
well-being, diabetes related quality of life and distress, medical treat-
ment experience, symptom distress, confidence in self-management and 
in access to person-centered diabetes care and support are important con-
structs to measure in order to evaluate outcomes of diabetes care which 
reflect the priorities and perspectives of those living with the condition. 
The second study showed that the Danish PRO diabetes tool was feasible 
and acceptable to use in routine ambulatory diabetes visits and improved the 
care experience for people with diabetes and their health care professionals. 
The third study involved the design of a national multi-center study to evaluate 
the benefits of the tool in 7 diabetes care centers involving more than 550 people 
with diabetes and 30 health professionals. Interim results from this study con-
firm that the PRO diabetes tool facilitates active participation of people with 
diabetes and improves care by focusing on what matters most to the individual. 
The thesis describes the development and value of new methods and tools for 
systematic patient involvement in the design of PRO tools for clinical care. 
The national Danish PRO diabetes tool, co-developed with people with di-
abetes and health professionals is now approved for use in Denmark and 
implementation is ongoing.
